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Adipose tissue lies at the core of energy metabolism, by not only releasing and taking up 
fatty acids (FA) according to the individuals energy requirements, but also signaling other tissues 
to regulate their own metabolism. If adipose tissue function is lost, insulin resistance, 
hypertriglyceridemia and hepatic steatosis can develop. Despite understanding how adipocytes 
function in normal and diseased states, preadipocytes, which can safeguard against adipocyte 
dysfunction by differentiating and joining the adipocyte pool, have been overlooked. 
Furthermore, how preadipocytes, which have a diminished capacity to esterify FA compared to 
adipocytes, are able to survive constant FA fluctuations within the adipose tissue depot without 
succumbing to lipotoxicity remains unclear. Therefore, how human preadipocytes sense and 
resist a mixture of FA (oleate, palmitate, stearate and linoleate) that resembles a healthy 
individual’s adipose tissue microenvironment was investigated. 
  Experiments using a novel real-time flow cytometry device show that the maximal rate of 
mitochondrial superoxide accumulation, hydrogen peroxide (H2O2) production, and lipid 
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peroxidation occurred within seconds of exposure to FA. Although mitochondrial ROS occurred 
in a transient fashion (within 2 hours), preadipocytes still experienced a loss in respiration 
through depletion of NAD+ and NADH that manifested into overt oxidative stress and cell death 
after 24 hours of FA exposure. Despite observing cell death in 35% of our population, the 
majority of preadipocytes were able to mount a protective response through increases in the 
mitochondrial antioxidant buffering capacity. Investigation into FOXO1, one of the transcription 
factors that govern mitochondrial antioxidant gene transcription, revealed an increase in 
deacetylation as soon as six hours post FA exposure. Inhibition of FOXO1 or SIRT1, which 
deacetylates FOXO1, exacerbated the toxic effects of FA suggesting that the SIRT1-FOXO1 axis 
may play a beneficial role in protecting preadipocytes from constant exposure to FA. 
Furthermore, SIRT1, FOXO1 and mitochondrial antioxidant gene expression from human 
adipose tissue was correlated to insulin sensitivity further highlighting the potential importance 
of mitochondrial antioxidant buffering systems in adipose tissue function. Altogether, this study 
suggests that the preadipocyte survivability is centered on mitochondrial resistance to FA-
induced ROS through up regulation of mitochondrial antioxidant systems. 
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CHAPTER 1:  REVIEW OF THE LITERATURE 
In the developing world, rates of obesity are reaching epidemic proportions (Dinsa, 
Goryakin, Fumagalli, & Suhrcke, 2012). An accumulating body of literature suggests that 
adipose tissue dysfunction in obesity leads to ectopic fat accumulation and the development of an 
array of diseases (Abbasi, Brown, Lamendola, McLaughlin, & Reaven, 2002; A. Gastaldelli et 
al., 2002; Ravussin & Smith, 2002). However, irrespective of body weight, adipose tissue 
dysfunction can cause insulin resistance, hypertriglyceridemia and hepatic steatosis, suggesting 
that adipose tissue susceptibility should not be looked at in terms of obesity alone (P. Arner et 
al., 2011). One proposed mechanism as how adipose tissue dysfunction occurs is from failure of 
adipose tissue turnover by either a loss in preadipocyte number or differentiation capacity (J. 
Smith, Al-Amri, Dorairaj, & Sniderman, 2006).  Once a reduction in preadipocyte number or 
differentiation capacity occurs, mature adipocytes will store an overabundance of fatty acids 
(FA) and enter a hypertrophic/dysfunctional state (E. Arner et al., 2010; Heilbronn, Smith, & 
Ravussin, 2004; J. Smith et al., 2006). Although numerous studies have focused on the role of 
the adipocyte (Ahmadian, Wang, & Sul, 2010; DeFronzo, 2004; Varlamov et al., 2010; Wang et 
al., 2010), how preadipocytes function in an environment of constant exposure to FA levels has 
not been investigated.   
Preadipocytes, which are located within close proximity to lipid filled mature adipocytes, 
are in constant exposure to FA at much higher levels than other cell types of the body in both the 
healthy and diseased state (Tahiri, Karpe, Tan, & Cianflone, 2007). However, the elevation in 
intracellular levels of FA, seen during overnight fasting, may come at a price of increased 
reactive oxygen species (ROS) generation, specifically mitochondrial superoxide and hydrogen 
peroxide (H2O2) (Lambertucci et al., 2008; P Schönfeld & L Wojtczak, 2008). If preadipocytes 
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fail to mount a protective response in the face of increased ROS generation, oxidative stress and 
cell death can occur. Studies on the effects of FA on preadipocytes revealed a transient increase 
in mitochondrial superoxide, H2O2 and lipid peroxidation. This initial mitochondrial superoxide 
and/or alkyl radical production is linked to a cascade of events that lead to decreased NAD
+
 
levels, a loss of mitochondrial inner membrane potential (MIMP), diminished mitochondrial 
respiration, reduced ATP, and ultimately lead to the preadipocytes’ demise. Although almost 
one-third of cells died, the majority of cells survived, suggesting a protective mechanism against 
FA toxicity existed. Gene expression from preadipocytes indicated an upregulation of 
mitochondrial antioxidant genes following FA exposure. Examination of FOXO1, one of the 
transcription factors that govern mitochondrial antioxidant gene transcription, revealed an 
increase in deacetylation as soon as six hours post FA exposure. Inhibition of FOXO1 or SIRT1, 
which deacetylates FOXO1, exacerbated the toxic effects of FA suggesting that the SIRT1-
FOXO1 axis may play a beneficial role in protecting preadipocytes from constant exposure to 
FA. Gene expression profiles between adipose tissue obtained from insulin-sensitive and insulin-
resistant individuals revealed that antioxidant genes regulated by the SIRT1-FOXO1 axis were 
lower in insulin resistance suggesting the protective effect of mitochondrial antioxidant gene 
expression in preserving adipose tissue function. 
The survey of literature will examine why the choice was made to investigate the effects 
of FA in preadipocytes rather than adipocytes. Highlights from this section include how adipose 
tissue and preadipocytes function within an adipose tissue environment in the context of daily 
fluctuations of FA, the impact of FA on mitochondrial fitness and how the prototypical SIRT1-
FOXO1 stress response may serve to protect against FA-induced lipotoxicity.    
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Adipose Tissue: The Body’s Fat Stores  
From the beginning of human history, the ability to survive required that individuals store 
calories in the form of triacylglycerol that is used as fuel during periods of low food availability. 
The main cell type that performs this process of lipid storage and release is the white adipocyte 
(Frayn, 2002). Two other main adipocyte cell types have been identified, the brown and beige 
adipocyte. Unlike white adipocytes, brown and beige adipocytes use FA almost exclusively for 
thermogenesis rather than storage (Cinti, 2006; Lidell et al., 2013). The locations of brown 
adipose tissue are found exclusively around the thorax, neck, and vertebrata, while beige 
adipocytes are located within white adipose tissue (Wu et al., 2012). Since an increase in caloric 
intake can involve expansion of white adipose tissue to store excess calories as fat (Gray & 
Vidal-Puig, 2007; J. Y. Kim et al., 2007; J. Smith et al., 2006), the focus of this review of 
literature will be on the role of white adipocytes, and specifically their progenitors, the white 
preadipocytes. 
White adipose tissue develops around sites of loose connective tissue such as 
subcutaneous layers between the muscle and the dermis; however, adipose specific depots also 
form around the heart, kidneys and other internal organs (Gray & Vidal-Puig, 2007). The three 
main adipose tissue depots responsible for FA trafficking are 1) visceral, the adipose tissue 
surrounding the major abdominal organs, 2) lower body subcutaneous and 3) upper body 
subcutaneous (Paolisso, Gambardella, et al., 1995). Although each adipocyte depot functions to 
store FA, their contribution to the uptake and release of FA is different. For example, although 
visceral fat has a higher rate of FA release than subcutaneous fat, it contributes very little to 
systemic levels of non-esterified fatty acids (NEFA) (P. Arner, 2005; Gil, Olza, Gil-Campos, 
Gomez-Llorente, & Aguilera, 2011). Therefore, the major contributor to circulating NEFA is 
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from subcutaneous adipose tissue, and specifically from the upper body region (Koutsari, Ali, 
Mundi, & Jensen, 2011; Koutsari, Snozek, & Jensen, 2008). Because of its preponderant role in 
extracting circulating FA, it has been hypothesized that failure of subcutaneous adipose tissue to 
store FA into neutral lipids essentially triacylglycerol, causes an efflux of FA to ectopic sites 
including visceral adipose tissue, liver and muscle (Ravussin & Smith, 2002). As FA are 
recognized to be cytotoxic for most non-adipocyte cells, increased FA exposure could explain 
the onset of systemic metabolic abnormalities (Unger, Clark, Scherer, & Orci, 2010a).  
The Preadipocyte: Guardian of Adipose Tissue Turnover 
Adipocytes are renewed throughout our lifetime, with roughly 10% of fat cells being 
renewed annually between the ages of 20 and 50 (Spalding et al., 2008). Therefore, 
preadipocytes, the progenitors that differentiate into new adipocytes, are an important adipose 
tissue cell type in their own right. Irrespective of body weight, if adipose tissue turnover fails to 
store FA, preexisting adipocytes will take up an overabundance of FA and enter a hypertrophic 
(abnormally enlarged) state (DeFronzo, 2004; Ravussin & Smith, 2002; Sethi & Vidal-Puig, 
2007). Ultimately, hypertrophic adipocytes become insulin resistant and fail to take up FA 
leading to an elevation in the basal circulating NEFA level and perhaps furthering exacerbating 
an already dysfunctional adipose tissue depot (E. Arner et al., 2010; Gray & Vidal-Puig, 2007; J. 
Smith et al., 2006). Although the current understanding of how adipocytes function in a diseased 
state is characterized (DeFronzo, 2004; Hegele, Joy, Al-Attar, & Rutt, 2007), how other adipose 
tissue cell types function in diseased states or even in healthy environment is not as clear. One of 
these cell types that has the biggest impact on overall adipocyte function, is the preadipocyte. A 
reduction in preadipocyte number or adipogenic potential has been correlated with the increase 
in hypertrophic adipocytes and the onset of metabolic abnormalities (E. Arner et al., 2010; 
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Tchoukalova, Koutsari, & Jensen, 2007). The reason why there is a decrease in the number of 
preadipocytes, preadipocyte fitness and/or preadipocyte adipogenenic potential is not known. 
As discussed earlier, adipose tissue, serves to convert cytotoxic FA into less damaging 
neutral lipids, thereby protecting other tissues from their lipotoxicity (DeFronzo, 2004). Since 
preadipocytes are located near FA-releasing adipocytes, they are periodically exposed to high FA 
concentrations even in healthy individuals. For example, Tahiri et al., demonstrated that the 
adipose venous NEFA concentrations far exceeds the arterial NEFA concentration, indicating 
that cells within the adipose depot are exposed to two to three times higher FA concentrations 
than non-adipose depot cells independent of the diseased state (Tahiri et al., 2007). Although the 
role of FA on adipocytes has been the focus of several studies (DeFronzo, 2004; Koutsari et al., 
2011; M. Nguyen et al., 2005; Shadid, Koutsari, & Jensen, 2007; A. Subauste & C. Burant, 
2007; Wang et al., 2010; Wang, Zang, Ling, Corkey, & Guo, 2003), FA effects on preadipocytes 
have been overlooked for some time. This may be due to the misguided thought that the 
adipocyte lineage is immune to the deleterious effects of FA because of their efficiency to 
neutralize FA into triacylglycerol; however, it has recently been shown that a supraphysiological 
concentration of 250 μM of palmitate when bound to 85 μM BSA can increase death in both rat 
and mouse preadipocytes (Guo, Wong, Xie, Lei, & Luo, 2007).   
Fatty Acids: Too Much For Too Long 
In humans, circulating NEFA and adipose tissue represents the largest reservoir of FA 
(Bernardi, Penzo, & Wojtczak, 2002). In the circulation, FA are present at FA: albumin ratios 
that rarely exceed 1:1 except during prolonged exercise, fasting, disease and at locations directly 
around adipose tissue where FA release/uptake is the highest (Curry, Brick, & Franks, 1999; Don 
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& Kaysen, 2004; Yamazaki, Inagaki, Kurita, & Inoue, 2005). Although the plasma NEFA 
concentration is often lumped together as one entity, it represents a mixture of individual FA 
with different characteristics. The four main FA that comprise nearly 95% of circulating NEFA 
are the saturated FA, palmitate and stearate, and the unsaturated FA, oleate and linoleate. 
Mittendorfer et al, demonstrated that during the fasting basal state, the total plasma NEFA 
concentration was comprised of 26% palmitate, 13% stearate, 38% oleate, and 17% linoleate 
(Mittendorfer, Liem, Patterson, Miles, & Klein, 2003). Surprisingly, infusion of epinephrine to 
stimulate adipocyte lipolysis did not change the percent of each FA although the total NEFA 
concentration had increased from a mean of 371 µM to 1048 µM (Mittendorfer et al., 2003). 
Studies measuring NEFA levels during fasting from plasma of obese and lean children, and 
patients with metabolic syndrome reported similar individual FA percentages, with the mean 
difference in percent composition of each FA differing less than 5% between lean or obese 
children or adults with metabolic syndrome (Novgorodtseva et al., 2011; Sabin et al., 2007). 
Although fasting NEFA mixture levels appear to be similar after fasting, following a meal 
containing fat, the composition can vary based on what fat the meal contained. In a process 
called spillover, FA hydrolyzed from chylomicrons and not taken up by adipocytes, will join the 
circulating plasma NEFA pool influencing the mixture of FA (Fielding et al., 1996; Heimberg, 
Dunn, & Wilcox, 1974). Therefore, the biggest influence on the NEFA composition comes 
directly after a meal. The change in fatty acid composition, however, is short lived, as NEFA 
composition appears to equilibrate rapidly during the postprandial period.  Throughout our 
experiments, this basal FA composition will be used to try to mimic physiological situations in 
which FA are elevated for a prolonged period of time like postabsorptive or fasting periods. It 
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will help us to define the threshold at which lipotoxicity may occur and the mechanisms 
involved. 
Impact of Fatty Acids on Mitochondrial Reactive Oxygen Species Emission  
Although reactive oxygen species (ROS) serve in normal physiological signaling, if ROS 
are generated at a rate above the buffering capacity of the cell, they can become a toxic by-
product, and have been linked to a wide variety of metabolic diseases including T2DM (Murphy, 
2009).  In mammalian tissues, four main types of ROS exist: the free radicals superoxide anion 
(O2
-
) and hydroxyl radical (HO
.
), and the non-radical species H2O2 and singlet oxygen (
1
O2) 
(Orrenius, Gogvadze, & Zhivotovsky, 2007; P Schönfeld & L Wojtczak, 2008). If ROS 
generation is above the buffering capacity of the mitochondrion, lipid peroxidation as well as 
redox-dependent protein modifications can occur leading to a loss in mitochondrial electron 
transport efficiency, membrane potential and inner membrane permeabilization (Orrenius et al., 
2007). This is of importance because these consequences have a negative impact on cellular 
respiration and result in cell death.  
After they enter the cell, FA are activated by the addition of a free coenzyme group, 
generating a fatty acyl CoA that can be either esterified or oxidized (Binas et al., 2003; Schaap, 
Binas, Danneberg, van der Vusse, & Glatz, 1999). The fraction of fatty acyl CoA channeled for 
β-oxidation is shuttled into the matrix of the mitochondria by CPT1, CPT2 and Carnitine 
translocase (Drynan, Quant, & Zammit, 1996). Once in the mitochondrial matrix, fatty acyl Co-
A is oxidized to generate NADH and FADH2. NADH and FADH2 then pass electrons to the 
electron transport chain (ETC) due to their own negative redox potential, thus allowing electrons 
to travel down the chain to more positive redox potentials until they reduce oxygen, the final 
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electron acceptor to water (Brand, 2005; Brand & Nicholls, 2011). As electrons are passed along 
the chain, protons are pumped from the matrix through Complexes I, III, and IV and into the 
inner membrane space to generate a proton motive force that is used by the ATP synthase 
complex to form ATP (MITCHELL, 1961; Mitchell & Moyle, 1968). When ATP synthesis is 
low or the ability to pass electrons from complex to complex is interrupted, the ETC can become 
highly reduced (Wallace, Fan, & Procaccio, 2010).  Once the ETC is reduced, electrons and 
oxygen accumulate at electron carriers within the ETC, thereby increasing the probability of 
electrons interacting with oxygen to form superoxide (Skulachev, 1996).  
Several other hypotheses describing the mechanism by which FA induce ROS generation 
have been proposed. One explanation is that FA directly affects mitochondrial ETC machinery. 
Wojtczak et al., demonstrated in permeabilized mitochondria that Complex III becomes 
inactivated when exposed to palmitate in a concentration-dependent manner (P. Schönfeld & 
Wojtczak, 2007). Furthermore, inhibitory effects of palmitate on Complex I and depletion of 
cytochrome c by arachidonic acid have been observed (Cocco, Di Paola, Papa, & Lorusso, 1999; 
Di Paola, Cocco, & Lorusso, 2000; Loskovich, Grivennikova, Cecchini, & Vinogradov, 2005). 
FA can also change mitochondrial membrane fluidity and affect the ability of electrons to pass 
freely along the ETC, causing an increased probability of superoxide formation (P. Schönfeld & 
Struy, 1999; P. Schönfeld & Wojtczak, 2007; Stillwell, Jenski, Crump, & Ehringer, 1997).  
Once superoxide is formed, it is dismutated by superoxide dismutase 2 (SOD2) into 
H2O2. Following dismutation of superoxide to H2O2, detoxifying systems such as the glutathione 
peroxidases and peroxiredoxins reduce H2O2 to H2O. Mitochondrial glutathione peroxidases, 
especially GPX1, use reduced glutathione (GSH) to reduce H2O2 and release water and oxidized 
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glutathione (GSSG)(Cox, Peskin, Paton, Winterbourn, & Hampton, 2009; Lu, 2000). GSSG 
thereafter is restored to its reduced form by glutathione reductase (GSR), which sequentially uses 
two NADPH to reduce the prosthetic flavin adenine dinucleotide group that, in turn, reduces 
GSSG (Lei, 2002). Mitochondrial peroxiredoxins, specifically PRDX3, can interact with H2O2 to 
become oxidized and release water (Chae, Uhm, & Rhee, 1994; Cox et al., 2009). Thioredoxin, 
and its mitochondrial isoform, TRX2, serves to reduce the oxidized cysteine groups on proteins 
including oxidized PRX3 (Chae, Chung, & Rhee, 1994). By utilizing intra-mitochondrial 
NADPH a source of reducing equivalents, reduced TRX2 is regenerated by thioredoxin 
reductase (trxR) (Hansen, Zhang, & Jones, 2006; M. Liang & Pietrusz, 2007; Nonn, Williams, 
Erickson, & Powis, 2003). Other mitochondrial antioxidant defenses, such as phospholipid 
hydroperoxide glutathione peroxidase 4 (GPX4) can reduce hydroperoxide groups on 
phospholipids, lipoproteins and cholesteryl esters, in addition to being able to reduce H2O2 
(Pushpa-Rekha, Burdsall, Oleksa, Chisolm, & Driscoll, 1995).  
The NAD+ and SIRT1 Connection 
During fasting conditions, the level of carbohydrates in the blood goes down and the 
level of FA rises. This increased availability of FA for oxidation within the mitochondria of most 
cells leads to an increase in the mitochondrial level of reduced nicotinamide adenosine 
dinucleotide (NADH). At the same time, lower availability of glucose maintains or slightly 
increases the level of oxidized nicotinamide adenosine dinucleotide (NAD+). By having higher 
cytosolic and nuclear NAD+ concentrations, SIRT1, a cytosolic/nuclear nicotinamide adenosine 
dinucleotide (NAD+) dependent deacetylase, is activated. Once activated, SIRT1 will start 
deacetylation of target proteins within the nucleus. SIRT1 has a wide variety of targets that 
include several transcription factors including the tumor suppressor protein p53, FOXO1, 
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FOXO3, PPARγ, PGC1-α, and NFκB (H Huang & Tindall, 2007). When the body returns to a 
high carbohydrate state, the breakdown of glucose by glycolysis reduces the cytosolic NAD+ 
level, and SIRT1 is inactivated (Wallace et al., 2010). Since SIRT1 absolutely requires NAD+ 
for its enzymatic activity, it is important to understand the role of NAD+ synthesis and supply in 
the activation of SIRT1. 
There are two main pathways of  NAD+ synthesis:  the novo pathway, in which NAD+ is 
synthesized from L-tryptophane (Rongvaux, Andris, Van Gool, & Leo, 2003; Sauve, 2008), and 
the salvage pathway (Revollo, Grimm, & Imai, 2007). Nicotinic acid phosphoribosyltransferase 
(NAMPT) initiates the salvage pathway by converting nicotinamide, and 5’phospho-ribosyl-1-
pyrophohosphate (5’PRPP) to nicotinamide monoculecotide (NMN), which is the rate limiting 
step of this NAD+ synthetic pathway (Imai, 2011). Completion of NAD+ biosynthesis occurs by 
nicotinamide/nicotinic acid mononucleotide adenylyltransferae (NMNAT), which transfers 
adenine from ATP to NMN to form NAD+. Dietary niacin and its derivative, nicotinamide, are 
thought to be the main NAD+ precursors (Rongvaux et al., 2003).  
Deacetylation of FOXO: The Difference Between Life and Death 
Members of the FOXO family of proteins, in particular FOXO1 and FOXO3, function 
primarily as a transcription factor in the nucleus that modulate the expression of genes involved 
in apoptosis, cell cycle, DNA damage repair, oxidative stress, cell differentiation and glucose 
metabolism. High affinity DNA-binding studies have identified a consensus FOXO-recognized 
element (FRE) (Furuyama, Nakazawa, Nakano, & Mori, 2000). Functional FRE sites that match 
the consensus have been shown to correspond to the promoter of pro-apoptotic sequence genes 
such as Fas ligand (FASL) and tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) 
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and antioxidant detoxification genes such as catalase, glutathione peroxidase and SOD2 (Brunet 
et al., 1999; Malik & Storey, 2011; Modur, Nagarajan, Evers, & Milbrandt, 2002). Because 
FOXO proteins have a diverse array of transcriptional targets, regulation of FOXO proteins is 
essential in propagating the correct transcriptional changes that may serve to determine survival 
versus death for the cell. FOXO1, the best-characterized member of the FOXO family, has three 
main post-translational modifications,  phosphorylation, ubiquitylation and acetylation have been 
identified.  
AKT-phosphorylated FOXO1 binds to the chaperone protein, 14-3-3β, and becomes 
sequestered in the cytoplasm, where both are unable to regulate gene expression (Brunet et al., 
1999). Alternatively, FOXO1 can also be phosphorylated by several different kinases that lead to 
its sequestration to the cytoplasm (Brunet et al., 2001; H. Huang, Regan, Lou, Chen, & Tindall, 
2006; Woods et al., 2001).  The c-Jun N-terminal kinase (JNK) can indirectly effect FOXO1, by 
phosphorylating 14-3-3β, which leads to dissociation of 14-3-3β  from FOXO1, and nuclear 
localization of FOXO1 (Accili & Arden, 2004). Once in the nucleus, FOXO1 can be 
ubiquitylated by S-phase kinase-associated protein 2, ultimately leading to FOXO’s degradation 
(H Huang & Tindall, 2007).  
The third post-translational modification that can affect FOXO transcriptional activity is 
acetylation/deacetylation.  Acetylation of FOXO1 by p300 or  cAMP response element-binding 
protein-binding protein (CBP) causes FOXO1 to become more negatively charged (Daitoku et 
al., 2004; Kitamura et al., 2005). While CBP can acetylate FOXO1 directly, it plays a dual role 
by enhancing FOXO1 transcription, by acetylating histones and by allowing the formation the 
preinitiation complex (Daitoku et al., 2004; M. Li, Luo, Brooks, & Gu, 2002). SIRT1 can form a 
complex with, and deacetylate, FOXO1 in the nucleus. Deacetylated FOXO1 favors increased 
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binding to the promoters of genes encoding for antioxidant enzymes (Higuchi et al., 2012; G. R. 
Smith & Shanley, 2010). Silencing of FOXO1 has been demonstrated to blunt increases in 
SOD2, catalase and glutathione peroxidase (Higuchi et al., 2012). In combination with FOXO1, 
SIRT1 appears to inhibit the transcriptional activity of p53, and shift the FOXO1 function from 
cell death to survival (Langley et al., 2002; Vaziri et al., 2001).  
In mature adipocytes, it has been demonstrated that resveratrol, an allosteric activator of 
SIRT1, can increase FOXO1 protein levels, and increase SOD2 expression, in the presence of 
FA (Hubbard et al., 2013; A. R. Subauste & C. F. Burant, 2007). Therefore, for preadipocytes, 
the ability of FA to influence the SIRT1-FOXO1 axis may be important to resist lipotoxicity, to 
improve survival, and ultimately to protect adipose tissue turnover. 
Central Hypothesis 
Based on these observations, the central hypothesis to be tested is that preadipocyte 
exposure to a mixture of FA in the context of daily FA concentrations causes the production of 
intra-mitochondrial superoxide-derived reactive oxygen species (ROS) or alkyl radical 
overloads.  ROS overloads ultimately lead to a loss of respiration through increased 
mitochondrial inner membrane permeabilization and inner membrane depolarization, thereby 
decreasing ATP synthetic and H2O2 dissipating capacities. This loss in preadipocyte 
mitochondrial fitness would ultimately cause cell death.  Despite preadipocyte susceptibility to 
FA, preadipocytes are able to survive FA fluctuations through initiation of the SIRT1-FOXO1 
axis that governs mitochondrial antioxidant gene expression.   
Specific Aim #1. Determine the impact of FA on mitochondrial fitness and cell viability using a 
human SAT-derived preadipocyte cell line. 
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This is the topic of Chapters 2 -4: 
Specific Aim #2. Determine whether a SIRT1-FOXO1 axis elicits an antioxidant response that 
protects against sustained FA exposure. As a sub-aim investigate whether the loss of 
mitochondrial antioxidant gene expression, SIRT1 and FOXO1 is lower in insulin resistant 
versus insulin sensitive individuals. 
This is the topic of Chapters 5 and 6.  
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CHAPTER 2:  INTEGRATED MATERIALS AND METHODS 
Subjects 
All 32 subjects were women from eastern North Carolina, recruited through participating 
physicians performing abdominal surgery at Vidant Medical Center, and all subjects had given 
informed written consent. Subjects for this study were previously used in Rogers et al. to 
compare EGF Receptor (ERBB1) abundance in adipose tissue to markers of adipogenesis and 
proliferation (Rogers et al., 2012a). Their ages ranged from 25 to 61 years and their body mass 
indices (BMI) ranged from 20.7 to 54.7 kg/ m2. The protocol was approved by the East Carolina 
University Institutional Review Board (Appendix 1). All subjects were undergoing 
hysterectomies and were not taking drugs that could affect lipid or glucose homeostasis. BMI 
was calculated from body mass and height recorded at the time of surgery to the nearest 0.5 kg 
and centimeter, respectively. Fasting glucose was quantified from blood collected the day of the 
surgery using the 2300 Stat Plus System (Yellow Springs Instruments, Inc., Yellow Springs, 
OH). Insulin was quantified using the Beckman-Coulter Access Immunoassay System 
(Beckman-Coulter, Fullerton, CA). Abdominal subcutaneous adipose tissue (outside the fascia 
superficialis) was chosen because it constitutes the primary site of fatty acid storage and release, 
and hence would likely be a location where turnover is critical to maintaining fatty acid 
homeostasis (Koutsari & Jensen, 2006). The tissue was immediately frozen in liquid nitrogen, 
transported to the laboratory, and stored at -80
0
 C. For comparison purposes, the subjects were 
subdivided into four groups:  the insulin-sensitive lean (ISNO) [BMI_30 kg/m
2
, homeostasis 
model of assessment for insulin resistance (HOMA-IR) _2.6 (actual highest value was 1.7), 
fasting insulin 10 _IU/ml, and fasting glucose_110 mg/dL]; the insulin-sensitive obese (ISO) 
(BMI_30 kg/m
2
, HOMA-IR _2.6, fasting insulin _10 _IU/mLl, and fasting glucose _110 mg/dl); 
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the insulin-resistant obese (IRO) [BMI _30 kg/m
2
, HOMA-IR _2.6 (actual lowest value was 3.0), 
fasting insulin _10_IU/mL, and fasting glucose_126 mg/dL], and the T2DM (fasting glucose 
>126 mg/dL on two occasions). The HOMA-IR cutoff of 2.6 was determined from our data bank 
of 38 lean individuals with normal glucose tolerance based on the commonly used 75th 
percentile, and it is in line with previously reported cutoffs (Ascaso et al., 2003). For some 
comparisons, the subjects from the first and fourth quartiles were compared with respect to 
insulin sensitivity, regardless of their body weight. Analysis of data from 81 subjects for which 
there were both HOMA-IR and iv glucose tolerance tests, minimal model values established that 
the first and last quartiles of HOMA have a sensitivity of 0.9 to identify subjects belonging to the 
last and first tertiles of SI, respectively. These are more stringent HOMA-IR cutoffs than the 
above-described insulin-sensitive and insulin-resistant cutoffs. For other comparisons, we 
compared the subjects from the first and fourth quartiles with respect to SIRT1 and FOXO1 
protein levels.  
Cell Culture and Transfection  
XA15A1 human preadipocytes (Lonza Walkersville, Inc., Walkersville, MD) were 
cultured as described in Skurk et al.,(Skurk, Ecklebe, & Hauner, 2007) using Dulbecco's 
modified Eagle's medium: F12 (DMEM:F12; Mediatech, Manassas, VA) with 10% calf serum, 
15 mM glucose, 33 µM biotin, 17 µM D-pantothenate, 100 nM insulin, and 10 nM 
hydrocortisone (all from Sigma Aldrich), 1 nM epidermal growth factor and 1 nM basic 
fibroblast growth factor (Gemini, West Sacrameto, CA).  This medium also contained 50 IU/ml 
penicillin, 50 µg/ml of streptomycin and 2.5 µg/ml amphotericin B (Mediatech). The XA15A1 
cells were propagated at 33
°
C. When the cells reached 80% confluence, growth factors were 
omitted from the media and the cells were placed at 37
°
C for at least 24 hours prior to the 
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experiment. The XA15A1 cells express a temperature-sensitive mutant of the SV 40 Large T-
antigen (u19tsA58) and needs to be incubated at 37
°
C for 24 hours to revert to a phenotype that 
resembles that of primary cells and are able to differentiate. For some experiments, XA15A1 
cells were transiently transfected with Mito-HyPer or Cyto-HyPer plasmids (Evrogen, Moscow, 
Russia), which encode mitochondrion- or cytosol-targeted H2O2-sensitive ratiometric reporter 
proteins. For other experiments, the cells were transfected with plasmids coding for SIRT1 or 
FOXO1 dominant negative (DN) mutants obtained through the AddGene repository 
(Herscovitch, Perkins, Baltus, & Fan, 2012; J. Nakae, Barr, & Accili, 2000; Vaziri et al., 2001). 
The Sirt1 DN mutation causes an alteration of the catalytic site and leads to a loss in 
deacetylation activity (Vaziri et al., 2001). The Foxo1 DN mutant contains a deletion that 
truncates the transactivation domain (J. Nakae et al., 2000). Both the Sirt1 DN and Foxo1 DN 
plasmid encode for the puromycin resistance gene, for the selection of stably transfected cells. 
The two types of transfection were performed identically. Briefly, 5 x 10
6
 cells were transfected 
in a 100 μL final volume of the nucleofection solution V containing 1μg of plasmid DNA and the 
application of the T-030 program from the Amaxa Nucleofactor 2b electroporator (Lonza 
Walkersville) list. For experiments using transiently transfected cells, the cells were used 48 
hours later. For experiments using stably transfected cells, 10 ug/mL puromycin was added to the 
medium after 24 hours to select for cells that stably integrated the Puromycin resistance gene. 
The cells were used 4 to 6 passages later.  
 
 
17 
 
Preparation of Fatty Acids  
A 50 mM stock of each single fatty acid was prepared in 0.1 M NaOH. Each fatty acid 
stock was added to Dulbecco's modified Eagle's medium: F12 (DMEM:F12) containing 600 µM 
BSA, 5% calf serum, 10 mM glucose, 33 µM biotin, 17 µM D-pantothenate, containing 50 IU/ml 
penicillin, 50 µg/ml of streptomycin, and 2.5 µg/ml amphotericin B to reach a mixture consisting 
of 40% oleate, 25% palmitate, 20% linoleate, and 15% stearate. Each concentration was pre-
equilibrated for one hour with 600 µM BSA at 37
0
C. For all experiments, cells were incubated in 
600 µM BSA for at least 2 hours prior to the addition of the drugs or fatty acids (FA). To start 
the experiment FA mixtures were added to the 600 µM BSA at a 2x concentration to equal a 
final FA concentration of 1x.  
RNA Isolation, Reverse Transcription, and Quantitative Real-Time PCR 
RNA was isolated from frozen adipose tissue samples or from cell culture samples after 
various treatments. Pieces of frozen adipose tissue of approximately 100 mg were allowed to 
unfreeze in 1 mL of RNA later ICE (Applied Biosystems, Foster City, CA). These pieces were 
homogenized and RNA isolated using the TriReagent procedure as described by the supplier 
(Sigma Aldrich). TriReagent was used, as well, for the cell culture experiments. First-strand 
cDNA was synthesized from 5 µg total RNA with the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). Relative real-time TaqMan PCR was performed with 
primers and 6-carboxyfluorescein dye-labeled TaqMan probes (Applied Biosystems). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an endogenous control 
because it was found to be the most stable when compared to HPRT and POLII. Each reaction 
contained 5 ng cDNA from total RNA, in a total reaction volume of 10 µl. To prevent bias 
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toward a specific group, the relative expression was determined by the comparative threshold 
method (Δct) using all samples as reference. 
MitoSox Red and CM-H2-DCFDA Fluorescence Measurements 
MitoSox Red, the fluorescent probe hydroethidine coupled to the mitochondrion-
targeting hexyl triphenylphosphonium (TPP) cation was used as a mitochondrion-localized 
superoxide indicator (Invitrogen, Carlsbad, CA). The fluorescent probe 5-(and-6)-chloromethyl-
2',7'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2-DCFDA; also from Invitrogen) 
was used as a cytosol-localized mitochondrial crisis indicator. As the majority of DCF 
fluorescence relies on cytochrome c release from the mitochondria and cytosolic H2O2 oxidation 
of cytochrome C (Brömme, Zühlke, Silber, & Simm, 2008; Karlsson, Kurz, Brunk, Nilsson, & 
Frennesson, 2010).  These detection methods were used for end point as well as real-time 
experiments. At the end of the incubation periods for end point experiments, cells were washed 
with Dulbecco’s phosphate buffered saline, containing calcium and magnesium (DPBS) and 
incubated at 37°C, with 4 µM MitoSox Red or 6 µM of CM-H2DCFDA in DPBS for 35 and 45 
minutes, respectively. After loading of the fluorescence probe, cells were washed twice with 
DPBS. After preloading, cells were dissociated from the dishes by adding 1 mL of 10x TrpLe 
dissociation buffer (Life Technologies, Grand Island, NY) for 30 seconds, and after adding 1 mL 
of DPBS, collected through repeated aspirations and ejections. MitoSox fluorescence was 
measured using an Accuri C6 flow cytometer (BD, Franklin Lakes, New Jersey) at an excitation 
wavelength of 488 and a 585 ± 40 nm emission filter. H2-DCFDA fluorescence was measured 
using an excitation wavelength of 488 and a 535 ± 30 nm emission filter. The real-time approach 
will be described separately in addition to being the subject of an independent chapter.  
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Continuous Real-Time Flow Cytometry Analysis 
To quantify changes in fluorescence on a cell-by-cell basis over the course of minutes to 
hours an apparatus was invented that could be retrofitted to any flow cytometers not operating 
under pressurized conditions like the BD Accuri C6. Briefly, the apparatus consists of an open 
30 mL polypropylene receptacle (vial) surrounded by a water coil jacket, supplied by a heated-
circulating water bath, set to maintain the temperature at 37C. The vessel is sitting on a stir plate 
allowing a rapid dispersion of FA or drugs without interruption, as well as maintaining 
homogeneous cell sampling.  After loading of the fluorescence probe as described in their 
respective method subsection, cells were processed similarly, except for the final addition of 1 
mL of flow buffer, which consisted of Krebs’s ringer bicarbonate buffer (Sigma-Aldrich Co., St. 
Louis, MO) containing 600 µM fatty acid-free bovine serum albumin, 5% fetal calf serum, 33 
µM Biotin, 17 µM D-Pantothenate, 50 IU/ml penicillin, and 50 µg/ml of streptomycin instead of 
DPBS.  Cells were counted by gating the single cell population in the Forward Scatter (FCS-H) 
versus Side Scatter (SSC-H) density plot. The counted cells were suspended in flow buffer to 
obtain a final concentration of about 1x10
6
 cells in a total volume of 7 mL. The suspended cells 
were transferred into the 30 ml vial. A stir bar was added and rotated at 400 rpm to maintain the 
oxygen tension constant, to quickly distribute the added compounds, and to prevent cell 
clumping. The flow rate was adjusted to have a flow rate of 66 µL/minute and a core size of 22 
µm in order to analyze fluorescence levels from about 2000 cells in the live cell region per 
minute. Baseline fluorescence in each sample was measured for 3-5 minutes prior to the addition 
of 600 µM BSA (basal). After 5 minutes, different compounds were added directly to the 
sample.  
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Detection of Lipid Peroxide Formation 
Mitochondrial inner membrane localized lipid peroxidation was assessed using a C11-
BODIPY
581/591 
probe conjugated to a TPP cation moiety (MitoPerOx: Dr. Michael Murphy, 
MRC Mitochondrial Biology Unit; Cambridge, England, UK) (Prime et al., 2012). The reduced 
C11-BODIPY
581/591 
probe has a maximum emission wavelength of ~590 while the oxidized 
product displays a maximum emission wavelength of  ~520 nm in response to lipid peroxidation 
by hydroxyl and peroxy radicals  (Drummen, Gadella, Post, & Brouwers, 2004).  Briefly, cells 
were incubated, at 37°C, in DPBS with 150 nM MitoPerOx for 30 minutes. After loading, cells 
were collected and CRT flow cytometry or fluorescent microscopy was performed. For the CRT 
flow cytometry experiments, MitoPerOx was excited at a wavelength of 488 and emission 
captured through a 585 ± 40 nm and 535 ± 30 nm emission filters for the reduced and oxidized 
form of MitoPerOx, respectively. For the microscopy based experiments, cells were washed with 
1x PBS and 1 mL of flow buffer was added. Following an addition of flow buffer, images were 
taken at multiple time points with an EVOS fluorescent microscope (AMG, a part of life 
technologies, Grand Island, NY) using the GFP light cube, which couples a 470 ± 22 nm 
excitation and a 525 ± 50 nm emission filter, as well as the RFP light cube, which couples a 531 
± 40 nm excitation to a 593 ± 40 nm emission filter.  
Detection of Mitochondrial and Cytosolic H2O2  
H2O2  levels in the mitochondrial or cytosolic compartment were measured using the 
genetically encoded sensors Mito-HyPer (has a mitochondria targeted sequence) or Cyto-HyPer 
(which resides in the cytosol) that encode for a mutated OxyR protein that  is sensitive to 
submicromolar (or physiological) levels of  H2O2 (Belousov et al., 2006; Choi et al., 2001). 
HyPer has an emission of ~516 nm and an excitation of 420 and 500 nm. In the presence of 
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H2O2, the excitation peak of  HyPer at ~420 nm decreases proportionally to the increase of the 
excitation peak at 500 nm, allowing for the ratiometric measurement of H2O2.  For the studies, 
measurements of the ~516 nm emission peak was used with a 530± 30 nm emission filter, after 
using an excitation wavelength of 488 only. Cells were plated in six well dishes and grown for 
48 hours before CRT flow cytometry was performed. The cells were lifted as described in the 
CRT flow cytometry subsection and the FA added similarly.  
Cell Death 
Cell death was measured by Calcein AM and Ethidium Homodimer-1 (Life 
Technologies, Grand Island, NY). Calcein AM is a live cell dye that accumulates in intact cells 
where it acquires a strong green fluorescence upon cleavage by intracellular esterases 
(Papadopoulos et al., 1994). Because intracellular esterase activity is quickly lost as cells die, 
little to no gain in fluorescence occurs in dead or dying cells. Ethidium Homodimer-1 is a dye 
that enters the damaged plasma membrane and interacts with nucleic acids. As Ethidium 
Homodimer-1 interacts with nucleic acids the red fluorescence of the dye increases by 40 Fold, 
indicating dying or dead cells (Papadopoulos et al., 1994). At the end of the 6, 12 or 24 hour FA 
incubation periods, cells were collected and incubated for 15 minutes at room temperature in 
DPBS containing Calcein AM and Ethidium Homodimer 1 at a final concentration of 0.05 µM 
and 4 µM. To detect Calcein AM fluorescence an excitation wavelength of 488 and a 530± 30 
nm emission filter was used. Ethidium Homodimer 1 fluorescence was detected using an 
excitation wavelength of 488 and a 675 ± 25 emission filter. After subtraction of auto-
fluorescence, the live cell region was determined by examining an untreated sample and a 
sample containing only 600 µM BSA. Dead cells were determined by treating a control sample 
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with 0.01% Triton-X for 15 minutes. All values for cell death represent the percent of dead cells 
found in the gated region of the cell population of interest.  
Mitochondrial Inner Membrane Permeabilization  
As mentioned in the description of the use of Calcein AM for the identification of live 
cells, Calcein AM enters cells and has access to every compartment. Cobalt is known to quench 
Calcein fluorescence, but since cobalt  does not freely enter mitochondria, Calcein AM 
fluorescence within the mitochondria is not quenched unless there is an increase in membrane 
permeability (Petronilli et al., 1998). Briefly, cells are incubated with Calcein AM at a final 
concentration of 0.05 µM in DPBS for 30 minutes, followed by 200 µM CoCl2 for 15 minutes. 
Calcein AM fluorescence was measured using an excitation wavelength of 488 and a 535 ±30 
nm emission filter. Mean fluorescence and percent of cells experiencing mitochondrial inner 
membrane permeabilization was determined by histogram plots of Calcein AM after the 
subtraction of auto fluorescence.  
Detection of Changes in Inner Mitochondrial Membrane Potential 
Changes in inner mitochondrial membrane potential was measured by using the lipohilic 
cationic dye tetramethylrhodamine ethyl (TMRE) ester (Sigma-Aldrich Co) that accumulates in 
direct proportion to the inner mitochondrial membrane potential according to the Nernst 
Equation. Each sample was incubated with 50 nM TMRE in DPBS for 20 minutes at 37
0
C. 
TMRE was measured using an excitation wavelength of 488 and a 585 ±40 nm emission filter. 
Mean fluorescence was determined by histogram plots of TMRE fluorescence after the 
subtraction of auto fluorescence.  
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Measurement of the Ratio of Acetylated versus Total FOXO1 Proteins  
Following treatment with FA, 1.0x10
6 
cells were collected, fixed in 5% formaldehyde and 
permeabilized in 100% methanol. The non-specific binding of antibody on cells was blocked by 
incubating the cells for 60 minutes in an incubation buffer consisting of PBS containing 0.5 % 
BSA. After blocking, primary antibodies directed against total FOXO1 (sc-9808; Santa Cruz 
Biotechnology, Dallas, TX) or Ac-FOXO1 (sc-49437, Santa Cruz) were added at a 1:100 
dilution ratio in the incubation buffer. Cells were washed once and incubated with a 1:1000 
dilution of anti-goat IgG (H+L) Alexa Fluor 568 (A11057; Life technologies) and a 1:1000 
dilution of anti-rabbit IgG (H+L) Alexa Fluor 488 (4412; Cell Signaling Technology) for 30 
minutes to reveal the total and acetylated FOXO1 antibody, respectively. Alexa Fluor 488 has an 
excitation of 488 nm and an emission of 520 nm. Alexa Fluor 568 has an excitation of 568 nm 
and an emission of 600 nm. After 30 minutes, cells were washed twice and suspended in 300 µL 
of PBS and analyzed on a flow cytometer. Auto fluorescence and nonspecific staining were 
determined by using either normal anti-rabbit IgG (Sc-2027; Santa Cruz) or normal anti-goat IgG 
(Sc-2028; Santa Cruz Biotechnology) as isotype controls, after gating on the live cell population. 
Gates were applied to each histogram that corresponded to either the 530 ±30 nm band pass filter 
or the 585 ±40 nm band pass filter. Mean fluorescence intensity (MFI) for each histogram was 
determined after gating. The ratio of Ac-Foxo MFI to Total-Foxo2 MFI was calculated and 
plotted using GraphPad Prism. 
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Cellular Respiration Assay 
Approximately 20,000 preadipocytes in growth media without growth factors were 
seeded to each well of Seahorse XF24 plates (Seahorse Bioscience, MA) and grown for 24 hours 
at 37C before treatment with various inhibitors or FA. Four to six hours before the experiments, 
the media was changed to DMEM, containing 5% calf serum, 25 mM Hepes, 10 mM glucose 
and 600 µM FA-free BSA. An hour before FA treatments, inhibitors or their vehicle was added 
to the cells, and then FA were added at various concentrations (0 – 1000 µM) for 24 hours.  At 
the end of the incubation, cells were washed two times with 1 ml of phosphate-buffered saline 
with magnesium and calcium. Finally, 500 µL of Seahorse XF-DMEM medium containing 10 
mM glucose and 2 mM sodium pyruvate was added to the cells. Cellular respiration was 
measured as described previously by Herscovitch et. al., (Herscovitch et al., 2012) with the 
following slight modifications determined to be optimal in preliminary experiments. First, the 
measurement cycle consisted of 1 minute mix, 1 minute wait and three minutes measurement. 
Second, three basal rate measurements were taken, three after oligomycin injection, three after 
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) injection and three after 
Rotenone injection. Drugs were delivered through the ports at final concentrations of 1 µM for 
oligomycin, 500 nM for FCCP and 1 µM for Rotenone. Each of the three independent 
experiments were performed in triplicate.  
NAD
+
 and NADH Levels 
Following FA exposure, cells were washed twice with PBS. NAD+ levels were 
determined using a NAD+/NADH cell-based assay kit as described in the manual (Cayman 
Chemical, Ann Arbor, MI). After washing, cells were lysed, centrifuged and the supernatant was 
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used to measure NAD+ and NADH levels. In this assay, alcohol dehydrogenase converts ethanol 
to acetoaldehyde and yields NADH from the NAD+ present in the supernatant. After NADH is 
formed, it reduces the tetrazolium salt substrate (WST-1) into a highly colored formazan dye that 
absorbs at the 450 nm wavelength.  An Infinite 200 Pro Series plate reader was used to quantify 
absorbance. As more than 95% of the NAD in cells is oxidized this assay is essentially a NAD+ 
assay. 
ATP Determination 
Following FA exposure, cells were washed twice with PBS, and ATP was extracted by 
using the boiling water extraction method (Yang, Ho, Chen, & Hu, 2002). Following extraction, 
ATP levels were determined using an ATP determination kit, as described by the supplier (Life 
Technologies). An Infinite 200 Pro Series plate reader was used to quantify luminescence. 
Statistical Analysis  
Statistical analysis was performed with PRISM (GraphPad Software, San Diego, CA) 
version 5.00 for Windows. Differences between ISL, ISNO, IRO and T2DM individuals were 
assessed by a one-way ANOVA, followed by Tukey’s multiple comparison tests. Differences 
between the first and last quartiles of insulin sensitivity or gene expression were assessed using a 
two-tailed unpaired Student’s T test. For in-vitro studies, differences between H2O2, Diamide, 
Tert-Butyl Hydroperoxide, FA concentrations, 600 µM BSA and/or pretreatment with 
MitoTempo, Etomoxir, Carnosine, Cyclosporin A or Nicotinamide were assessed by a one-way 
ANOVA with a Tukey’s multiple comparison test. All values are reported as + SD. In all cases, a 
P value of less that 0.05 was used to indicate statistical significance between conditions. 
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Abstract 
A reduction in preadipocyte number or adipogenic potential correlates with the onset of several 
metabolic abnormalities. Although the underlying cause of preadipocyte dysfunction is 
unknown, one potential hypothesis is that preadipocytes are unable to resist the lipotoxic effects 
of fatty acids (FA) in the adipose tissue microenvironment, leading to an overall increase in 
preadipocyte oxidative stress. For preadipocytes, dynamic changes in FA associated uptake and 
oxidative stress can occur within a matter of seconds and can vary dramatically from cell to cell, 
making it a challenge to measure these short-lived events in a representative portion of the 
population in real-time. For this purpose, a device that maintains physiological temperature, 
evenly mixes compounds and can be retrofitted to an existing flow cytometer was developed to 
measure millisecond changes in preadipocyte FA uptake, oxidative stress and cytosolic H2O2. 
Results demonstrate that FA uptake rapidly reaches equilibrium within 10 seconds. However, 
despite observing mitochondrial crisis and H2O2 accumulation, with exogenous H2O2, tert-butyl 
hydroperoxide and diamide, the occurrence of oxidative stress or H2O2 emission during FA 
exposure was not observed. Together this data provides a foundation for use of continuous real-
time flow cytometry to study rapid changes in biological systems and suggests that while 
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preadipocyte take up FA within seconds, FA oxidative effects are compartmentalized within the 
first 3 hours of exposure. 
Introduction 
“As articulated so clearly by Skulachev, “Living with the risk of oxidative stress is a 
price that aerobic organisms must pay for more efficient bioenergetics” (Skulachev, 1996). The 
term oxidative stress is defined loosely as a series of interrelated phenomena including an 
elevated generation of reactive oxygen species (ROS) and oxidative damage to cell constituents 
(Andreyev, Kushnareva, & Starkov, 2005). Since the intracellular generation of ROS is 
considered an inevitable outcome of aerobic metabolism, balancing ROS production with 
detoxification mechanisms is an important contributor in shaping cellular processes. Therefore, 
measuring intrinsic rates of ROS generation is important for understanding the pathology of 
oxidative stress and associated disease states. For adipose tissue extracellular concentrations of 
fatty acids (FA) can levels that can lead to ROS and oxidative stress for most cells of the body 
(Frayn, Coppack, & Humphreys, 1993). The sensitivity of these cells depends on many factors; 
however, the two dominant factors are the energy required to perform their intended function and 
their triacylglycerol synthetic capacity (Unger, Clark, Scherer, & Orci, 2010b). Based on 
research performed in a variety of cell type, it has been hypothesized that mismatches between 
nutrient overload and ATP demand can manifest into excessive reductive pressures on the 
electron transport chain leading to superoxide-derived H2O2 production and eventually emission 
toward other compartments, in particular the cytosol (E. J. Anderson et al., 2009; Bonnard et al., 
2008; Fisher-Wellman & Neufer, 2012; Murphy, 2009). Although transient bidirectional 
mismatches serve to fine-tune metabolic and signaling pathways, excessive H2O2 emission 
disrupts normal cellular functions including insulin sensitivity (Fisher-Wellman & Neufer, 2012; 
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Houstis, Rosen, & Lander, 2006). For preadipocytes, which have a diminished capacity to 
esterify FA, the influence of FA on preadipocyte function may increase H2O2 emission from the 
mitochondria leading to an increase in cytosolic oxidative stress, and ultimately the 
preadipocytes demise, which can have a grave impact on the overall health of the adipose tissue 
depot.  
Although a number of approaches are currently available to measure FA uptake, 
oxidative stress and cytosol H2O2 levels, several limitations exist. For example, plate reader-
based approaches have the unfortunate limitation of merging the individual cellular responses 
into combined readings while losing sight of cellular heterogeneity. Microscopy approaches 
follow events within a selected group of cells, but this is also their main limitation as only few 
cells at a time can be sampled.  Recently, Vines et al. reported that changes in intracellular Ca
2+
 
concentrations could be monitored on a single cell basis in a large cell population, using a non-
pressurized flow cytometer (Vines, McBean, & Blanco-Fernández, 2010). Using a similar 
approach, a device that could be retrofitted to a non-pressurized flow cytometer was developed 
to study in real-time the effects of FA on preadipocytes. 
The overall goal of this study was 1) to establish a method that allows for the real-time 
measurement of rapidly occurring biological process in living cells and 2) to determine the effect 
of FA exposure on preadipocyte FA uptake, oxidative stress and cytosolic H2O2. Data suggest 
that despite FA uptake occurring within seconds of FA exposure, H2O2 emission and subsequent 
oxidative stress does not occur within the first 3 hours of FA exposure. Furthermore, the data 
demonstrate that continuous real-time flow cytometry can be a useful tool that expands the 
ability of researchers to understand dynamic changes in cellular processes.  
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Materials and Methods 
Fatty Acid Preparation 
A 50 mM stock of each FA was prepared in 0.1 M NaOH. Each FA stock was added to 
Dulbecco's modified Eagle's medium:F12 (DMEM: F12) containing 600 µM BSA, 5% calf 
serum, 10 mM glucose, 33 µM Biotin, 17 µM D-Pantothenate, 50 IU/ml penicillin, 50 µg/ml of 
streptomycin, and 2.5 µg/ml amphotericin B to reach a mixture consisting of 40% oleate, 25% 
palmitate, 20% linoleate, and 15% stearate. Each concentration was pre-equilibrated for one hour 
with 600 µM BSA at 37
0
C. For all experiments, cells were incubated in 600 µM BSA for at least 
2 hours prior to the addition of drugs or FA. To start the experiments, FA mixtures were added at 
2X concentrations. For the FA uptake experiments, 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-
diaza-s-indacene-3-hexadecanoic acid (BODIPY FL C16; Invitrogen, Carlsbad, CA) replaced 4% 
of the palmitate in the mixture. 
Loading of the Cells with CM-H2-DCFDA 
The fluorescent probe 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate 
acetyl ester (CM-H2-DCFDA referred to here as H2-DCFDA; Invitrogen) was used as a cytosol-
localized mitochondrial crisis indicator (Brömme et al., 2008; Karlsson et al., 2010). Cells were 
washed with Dulbecco’s phosphate buffered saline containing calcium and magnesium (DPBS) 
and incubated for 45 minutes at 37°C with 6 µM of CM-H2DCFDA in DPBS. After loading, 
cells were washed twice with DPBS and the dye-loaded cells were dissociated from the dishes by 
adding 1 mL of TrpLe dissociation buffer (Life Technologies, Grand Island, NY) for 30 seconds. 
Cells were collected through repeated aspirations and ejections after adding 1 mL of flow buffer 
which consisted of Krebs’s ringer bicarbonate buffer (Sigma-Aldrich Co., St. Louis, MO) 
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containing 600 µM fatty acid-free bovine serum albumin, 5% fetal calf serum, 33 µM Biotin, 17 
µM D-Pantothenate, 50 IU/ml penicillin, and 50 µg/ml of streptomycin.  
Continuous Real-Time Flow Cytometry Analysis 
To quantify changes in fluorescence over the course of seconds to hours, a device that 
could be retrofitted to any flow cytometer not operating under pressurized conditions was built. 
We used a BD Accuri C6 was used (Figure 1). Briefly, the apparatus consists of an open 30 ml 
polypropylene receptacle (tube) surrounded by a water coil jacket supplied by a heated-
circulating water bath set to maintain the temperature at 37C. The receptacle sits on a stir plate 
allowing a rapid dispersion of FA or drugs without interruption, as well as maintaining 
homogeneous cell sampling. For all experiments, cells were counted after gating the single and 
live cell population. The counted cells were suspended in flow buffer to obtain a final 
concentration of about 400,000 cells in a total volume of 7 mL. The suspended cells were 
transferred into the 30 mL vial. A stir bar was added, and the suspension was rotated at 400 rpm. 
The flow rate of the pump was adjusted to 66 µL per minute and the core size set to 22 µm in 
order to analyze fluorescence levels from about 4,000 cells per minute before, and 2,000 cells per 
minute after the addition of test compounds as the final volume reached 14 mL. For the FA 
uptake experiments, the cells were suspended in the flow buffer (described in the loading of the 
cells with H2-DCFDA section). At time zero, flow buffer containing various concentrations of 
FA was added in order to achieve a final FA concentration ranging from 0 to 1000 μM. 
Fluorescence was measured using an excitation wavelength of 488 and a 585 ± 40 nm emission 
filter.  For the H2-DCFDA experiments, the baseline fluorescence of the loaded cells was 
measured for 2 to 3 minutes prior to the addition of various concentrations of FA (0 to 1000 
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μM), H2O2 (0 to 100 μM), 100 μM tert-butyl hydroperoxide (t-BHP) or 1 μM of diamide. H2-
DCFDA fluorescence was measured continuously for up to 3 hours (FA) or 20 minutes 
(everything else) at an excitation wavelength of 488 and a 535 ± 30 nm emission filter. Although 
pHyPer Cyto is a dual-excitation ratiometric H2O2 sensor, the Accuri C6 can only detect the 
oxidized pHyPer; therefore, an excitation laser wavelength of 488 coupled to a 535 ± 30 nm 
emission filter was used.  
Results and Discussion 
Fatty acids (FA) have been shown to elicit cytotoxic effects in a large variety of cell types 
including preadipocytes and adipocytes. The goal of this study was to develop an approach that 
can be used to characterize various events involved in FA-induced preadipocyte dysfunction in 
real-time. To accomplish this task, a device that maintains physiological temperature, evenly 
mixes compounds and can be retrofitted to non-pressurized flow cytometers was developed 
(Figure 1). For traditional flow cytometers, samples are placed in tubes that are then pressurized 
by the flow cytometer in order to draw the sample into the machine. Therefore, addition of 
compound requires the sample to be taken off the cytometer and a loss in recording occurs. By 
using a flow cytometer that uses a peristaltic pump to draw up the sample, the sample tube can 
be open and allows for the addition of compounds to the sample without interrupting the 
recording of events.  
 Although preadipocytes belong to the adipocyte lineage, the effect on FA exposure on 
preadipocytes is not known, especially in the context of FA concentrations found in the adipose 
tissue microenvironment. Before examining how FA exposure affects preadipocyte oxidation, 
the ability of preadipocytes to take up FA and if the real-time flow cytometry device could detect 
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rapid changes in FA entrance into preadipocytes was explored. As shown in Figure 2B to 2F, 
there was a rapid increase in BODIPY FL C16/FA fluorescence after the addition of FA. This 
increase in fluorescence was proportional to the FA concentration. To ensure that cellular uptake 
of fatty acids was being observed, two control experiments were performed. In the experiments 
illustrated in Figure 1G, cells were incubated with 1000 μM unlabeled FA to ascertain that the 
measured increase in fluorescence was not due to auto-fluorescence.  Furthermore, Figure 1H 
illustrates cells fixed prior to FA exposure showed no measurable increase in fluorescence, 
indicating nonspecific FA absorption was not the cause of the increased fluorescence in live 
cells. As no increase in fluorescence was observed in both these control experiments, it can be 
confidently reported that there is true documentation of FA uptake. Also noteworthy is the time 
necessary to reach the apparent equilibrium of FA inside versus outside, as seen in Figure 1B to 
1F. This observation is in line with results reported by others (Caserta et al., 2001; Kampf, 
Parmley, & Kleinfeld, 2007). For example, Kampf et al (Kampf et al., 2007)have shown rapid 
uptake of oleate by murine preadipocyte cell lines that were injected with the fluorescent fatty 
acid sensor ADIFAB and Caserta et al (Caserta et al., 2001) have shown rapid uptake of oleate 
by rat and human preadipocytes that were loaded with the pH indicator 2’,7’-bis(2-
carboxyethyl)-5,(6)-carboxyfluorescein (BCECF). Nevertheless, the flow cytometry data 
reported here gave comparable results to microscopy (data not shown), however, the flow 
cytometry methods allowed for a sampling rate in the thousands, dramatically increasing the 
power of the analysis.  
The second method illustrates that the device renders flow-cytometry suitable to 
document, also in real-time, events that may develop over periods of minute to hours. For this 
purpose, measurements of H2DCFDA fluorescence, which is an index of mitochondrial and/or 
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oxidative stress, were taken. To ensure our device was able to measure changes H2DCFDA 
fluorescence a variety of widely utilized oxidative agents were used (Figure 2). As shown in 
Figure 2A to 2D, the addition of increasing concentrations of H2O2 led to a rapid increase in 
H2DCFDA fluorescence. The rate of appearance of H2DCFDA fluorescence was clearly higher 
at the highest concentration of exogenously added H2O2 (Figure 2D). How H2O2 increases 
cytochrome c release from the mitochondria is not fully elucidated. However, oxidation of 
cardiolipins and mitochondrial outer membrane permeabilization are two important steps in the 
process (Ott, Robertson, Gogvadze, Zhivotovsky, & Orrenius, 2002). Therefore, the higher H2O2 
concentrations leading to faster release of cytochrome c was consistent with this hypothesis. 
Figure 2E shows that tert-butyl-hydroperoxide, an analog of lipid peroxides that mimics lipid 
peroxidation products, causes an increase in H2DCFDA fluorescence, likely due to cytochrome c 
release, as well as mitochondrial H2O2 emission (Haidara, Morel, Abalea, Gascon Barre, & 
Denizeau, 2002). Finally, Figure 2F shows that diamide, a general thiol-oxidizing agent that 
reacts with glutathione and decreases its availability for enzymes like glutathione S-transferases 
or glutathione peroxidases, also increases H2DCFDA fluorescence (Edelhauser, Van Horn, 
Miller, & Pederson, 1976). Consistent with diamide mechanism of action, figure 2F additionally 
shows that the rate of appearance of H2DCFDA fluorescence was slow, but progressive. 
Altogether, these results presented in figure 2 confirm that flow cytometry can be used to 
monitor processes occurring over several minutes in real-time.      
Although FA have been shown to induce oxidative stress in adipocytes, high FA 
concentrations will put an even greater reductive pressure on the mitochondria of preadipocytes, 
since preadipocyte have a diminished capacity to esterify FA, and potential causing an increase 
in H2O2 emission and oxidative stress (Gao et al., 2010; A. R. Subauste & C. F. Burant, 2007; 
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Yeop Han et al., 2010). Figure 3A shows that normal fasting FA concentrations (1000 μM FA 
conjugated to 600 μM BSA) did not cause overt oxidative stress within the first hour. Figure 3B 
illustrates that increasing the FA concentration to a level only seen during prolonged fasting 
(starvation) or a bout of exercise (2000 μM) did not cause signs of oxidative stress within an 
hour either. In fact, increasing the incubation time to almost three hours was insufficient to cause 
an increase in H2DCFDA fluorescence (Figure 3C). To directly measure H2O2 emission the cells 
were transfected with pHyPer Cyto, a selective cytosolic H2O2 sensor that displays nanomolar 
sensitivity (Figure 3D). As Figure 3D illustrates, while 100 μM extracellular H2O2 was able to 
transiently (back to basal levels by 30 minutes) increase cytosolic concentration of H2O2 to 
measurable levels, 1000 μM of FA did not. This is consistent with the published time course of 
H2O2 handling by living cells, which shows that it takes between 15-20 minutes for Hela or NIH-
3T3 cells to dissipate 100 µM H2O2 (Markvicheva et al., 2011). More importantly, it confirms 
the relative resistance of preadipocytes to FA-induced oxidative stress by use of a mixture of FA 
at physiological FA: BSA ratios. Additionally, there is the possibility that much longer 
incubation times are required to establish mitochondrial crisis, as most of the cited studies 
exposed the cells to FA for at least 24 hours.  
Although no changes in FA induced oxidative stress or H2O2 emission occurred, the 
ability of the continuous real time flow cytometry device to measure rapid changes in FA uptake 
and cytosolic oxidation by H2O2, tert-butyl hydroperoxide and diamide was observed. As any 
fluorescent probe can be used, the repertoire of applications is almost limitless and permits the 
simultaneous measurement of multiple readouts. Furthermore, the ability of real-time flow 
cytometry to measure a large portion of the population has a clear advantage over other methods 
that do not have the sampling power to identify subsets of the population.  
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Figure 1:  Mixing and sampling device that allows for continuous real-time (CRT) flow 
cytometry. 
Cells are loaded into the receptacle (sample tube). The maintenance of the sample temperature is 
assured by a heated water coil jacket connected to a heated circulating water bath. A stir plate 
serves not only to keep the cells in a homogeneous suspension, but also allows the added 
compounds to equilibrate and reach all the cells rapidly. The apparatus was placed in a manner 
such that the cytometer could aspirate sample without interference.  
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Figure 2. Uptake of fatty acids by human preadipocytes is rapid. 
Time course of uptake of fatty acids in human preadipocytes evaluated using BODIPY FL C16 
(fluorescent palmitate that has an excitation wavelength of 488 and emission wavelength of 590 
nm) uptake as an index of fatty acid uptake as described in the materials and methods section. 
Cellular autofluorescence before and after (arrow) the addition of fresh 600 μM BSA was 
measured (A). Concentration-dependent increases in fluorescence after the addition of 200 (B), 
400 (C), 600 (D), 800 (E) or 1000 (F) μM of FA. No increase in fluorescence was measured with 
label-free 1000 μM FA (G) or in cells that were fixed prior to the addition of 1000 μM of FA 
(H).  The arrows indicate the time at which fatty acids were added.    
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Figure 3. Various models of oxidative stress-induced mitochondrial crisis. 
Time course of H2DCFDA fluorecence measured with an excitation wavelength of 488 and an 
emission filter 535 ± 30 nm as described in the materials and methods section (A-F). The arrows 
indicate the time at which the agents were added. H2DCFDA fluorescence was measured up to 
12 minutes after the addition of buffer alone (A) or freshly prepared 5 (B), 50 (C) 100 (D) µM 
H2O2. Similar time courses were performed with 100 µM Tert-butyl hydroperoxide (E) or 1 µM 
Diamide (F).  
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Figure 4. Fatty acids do not promote acute mitochondrial crisis nor do they promote 
cytosolic H2O2 accumulation 
Time course of H2DCFDA fluorecence measured with an excitation wavelength of 488 and an 
emission filter 535 ± 30 nm as described in the materials and methods section (A-C). The arrows 
indicate the time at which the agents were added. In three independent experiments, H2DCF 
fluorescence was measured for 60 minutes after the addition of 1000 (A) or 2000 (B) μM FA. In 
two experiments, H2DCFDA fluorescence was measured for at least 160 minutes after the 
addition of 1000 (c) μM FA. In those experiments, there was no significant increase in 
fluorescence. Alternatively, we measured H2O2 directly using cells transfected with pHyPer Cyto 
(D). This method confirmed the absence of H2O2 emission following FA exposure and confirmed 
that H2O2 levels are only transiently increased, even after the addition of a supra-physiological 
concentration of H2O2. In the bar graph data are the mean ± SD of three independent 
experiments. * P ≤ 0.05 when compared to 600 µM BSA. 
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Abstract 
Elevated circulating non-esterified fatty acids (NEFA), a key feature of obesity, are a risk 
factor for Type 2 Diabetes (T2DM) and several cardiovascular diseases (CVDs). Since a 
lessened ability of adipocytes to store and retain fatty acids (FA) underlies the elevation of 
NEFA that is observed in obesity, understanding the cause of this elevation in NEFA due to 
adipose tissue dysfunction is important in preventing the development of metabolic disease. One 
potential hypothesis as to how adipose tissue dysfunction develops is due to a loss in 
preadipocyte number or adipogenic potential. One potential way that preadipocyte loss occurs is 
through an increased susceptibility to the constant flux of FA in and out of the adipose tissue 
depot.Furthermore how changes in FA levels affect preadipocyte function is not known. Using 
conditionally immortalized human preadipocytes, the effects of a physiologically relevant 
mixture of FA on mitochondrial and cellular redox, metabolic fitness and cell viability were 
tested. A FA concentration above 600 µM initiated a transient, rather than a persistent elevation 
of intra-mitochondrial superoxide (< 30 min), H202 (< 60 min) and inner mitochondrial 
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membrane lipid peroxide (< 120 min) production that could be prevented by use of 
mitochondrial selective scavengers of superoxide and alkyl radicals.  Similar changes in 
cytosolic redox parameters were not observed within the first twelve hours, demonstrating that 
mitochondrial reactive oxygen species (ROS) buffering systems were able to buffer this initial 
surge. A delayed and massive surge in cytosolic reactive oxygen species eventually occurs, but it 
is preceded by a progressive depletion of NAD+ and coincides with the collapse of the inner 
membrane potential (ΔΨ), the opening of the mitochondrial permeability transition pore (mPTP), 
as well as a decrease in ATP synthesis and ultimately death.  Together the results reveal that FA 
induced ROS production does not follow the current paradigm of a massive ROS/oxidative event 
leading to cell death, but rather suggests that transient changes in redox homeostasis can prime 
preadipocytes for mitochondrial dysfunction and cell death. 
Introduction 
Currently, more than one-third of adults in the United States have a body mass index 
(BMI) above 30, which is accompanied by an escalation in obesity-associated health problems 
(Z. Li, Bowerman, & Heber, 2005; Olshansky, 2005; Shah & Braverman, 2012). Although the 
link between obesity and obesity-related-disorders, such as insulin resistance, has been 
demonstrated in several epidemiological and interventional studies, the underlying mechanism is 
unclear (P. J. Anderson et al., 1997; Pories & Dohm, 2009; Ravussin & Smith, 2002). To meet 
the storage requirements for increased intracellular lipids, adipocytes can increase in either size 
(hypertrophy) or number (hyperplasia) by recruiting preadipocytes to join the adipocyte pool and 
share the increased lipid load (P. Arner et al., 2011). While hyperplasia and hypertrophy play a 
role in obesity, the ability of the adipose tissue depot to replace dysfunctional adipocytes, as well 
as to increase the number of mature adipocytes is compromised (P. Arner et al., 2011; Paolisso, 
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Gambardella, et al., 1995; Paolisso, Tataranni, et al., 1995). If adipose tissue turnover fails, 
ectopic fat accumulation occurs in the liver, muscle and other non-adipose tissue (A Gastaldelli 
et al., 2004; A. Gastaldelli et al., 2002; Moro, Bajpeyi, & Smith, 2008). One potential 
mechanism as to why adipose tissue turnover failure occurs is through a diminished preadipocyte 
pool due to an increased susceptibility to lipotoxicity within the normal day to day fluctuations in 
fatty acids (FA) (Tchoukalova et al., 2007). 
Depending on the equilibrium of FA outside versus inside the cell, FA can rapidly enter 
through the cellular membrane, interact with coenzyme A (CoA), and form fatty acyl-CoA 
(Kiens & Roepstorff, 2003). Once formed, fatty acyl-CoA can be shuttled into the mitochondria 
to be oxidized and generate reducing equivalents for ATP production via the electron transport 
chain (Wojtczak, 1976). If the NADH levels outweigh the preadipocytes ATP demand, one-
electron reduction of oxygen can occur at the level of the electron transport chain (ETC), 
forming superoxide and subsequently H2O2 (P Schönfeld & L Wojtczak, 2008) . Although levels 
of FA below a certain concentration pose no risk to mitochondrial or cellular functions, FA 
concentrations well-above physiological limits have been shown to increase mitochondrial 
complex I and III reactive oxygen species (ROS) generation in preadipocytes, and has been 
suggested based on work in other cell types to open the mitochondrial permeability transition 
pore (mPTP) and cause cell death (Guo et al., 2007; P Schönfeld & Bohnensack, 1997; P. 
Schönfeld & L. Wojtczak, 2008). Although reactive oxygen species (ROS) production of 
preadipocytes or adipocytes following fixed or prolonged (45 min to 7 days) FA exposure has 
been demonstrated, none have performed an extensive time course evaluation of fatty acid 
induced ROS production in preadipocytes (Guo et al., 2007). Additionally, understanding how 
FA influence mitochondrial fitness and survival have not been studied.  
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The objective of this study was to observe how human preadipocytes, in vitro, would 
respond to a FA-enriched environment.  The findings are that FA exposure initiates a transient 
rather than a persistent elevation of mitochondrial superoxide and H202 production that primes 
preadipocytes for cell death through depletion of NADH and NAD+. Together these results 
suggest that FA-induced ROS production does not follow the current paradigm of a massive 
ROS/oxidative event leading to cell death, but rather suggests a mechanism by which transient 
changes in mitochondrial ROS production can lead to mitochondrial dysfunction and cell death.  
Materials and Methods 
Cell Culture 
XA15A1 human preadipocytes (Lonza Walkersville, Inc., Walkersville, MD) were 
cultured as described in Skurk et al.,(Skurk et al., 2007) using Dulbecco's modified Eagle's 
medium: F12 (DMEM:F12; Mediatech, Manassas, VA) with 10% calf serum, 15 mM glucose, 
33 µM biotin, 17 µM D-pantothenate, 100 nM insulin, and 10 nM hydrocortisone (all from 
Sigma Aldrich), 1 nM epidermal growth factor and 1 nM basic fibroblast growth factor (Gemini, 
West Sacrameto, CA).  This medium also contained 50 IU/ml penicillin, 50 µg/ml of 
streptomycin and 2.5 µg/ml amphotericin B (Mediatech). The XA15A1 cells were propagated at 
33
°
C. When the cells reached 80% confluence, growth factors were omitted from the media and 
the cells were placed at 37
°
C for at least 24 hours prior to the experiment. The XA15A1 cells 
express a temperature-sensitive mutant of the SV 40 Large T-antigen (u19tsA58) and needs to be 
incubated at 37
°
C for 24 hours to revert to a phenotype that resembles that of primary cells and 
are able to differentiate. For experiments, XA15A1 cells were transiently transfected with Mito-
HyPer or Cyto-HyPer plasmids (Evrogen, Moscow, Russia), which encode mitochondrion- or 
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cytosol-targeted H2O2-sensitive ratiometric reporter proteins. Briefly, 5 x 10
6
 cells were 
transfected in a 100 μL final volume of the nucleofection solution V containing 1μg of plasmid 
DNA and the application of the T-030 program from the Amaxa Nucleofactor 2b electroporator 
(Lonza Walkersville) list. For experiments using transiently transfected cells, the cells were used 
48 hours later.  
Preparation of Fatty Acids 
A 50 mM stock of each single fatty acid was prepared in 0.1 M NaOH. Each fatty acid 
stock was added to Dulbecco's modified Eagle's medium: F12 (DMEM:F12) containing 600 µM 
BSA, 5% calf serum, 10 mM glucose, 33 µM biotin, 17 µM D-pantothenate, containing 50 IU/ml 
penicillin, 50 µg/ml of streptomycin, and 2.5 µg/ml amphotericin B to reach a mixture consisting 
of 40% oleate, 25% palmitate, 20% linoleate, and 15% stearate. Each concentration was pre-
equilibrated for one hour with 600 µM BSA at 37
0
C. For all experiments, cells were incubated in 
600 µM BSA for at least 2 hours prior to the addition of the drugs or fatty acids (FA). To start 
the experiment FA mixtures were added to the 600 µM BSA at a 2x concentration to equal a 
final FA concentration of 1x.  
MitoSox Red and CM-H2-DCFDA Fluorescence Measurements 
MitoSox Red, the fluorescent probe hydroethidine coupled to the mitochondrion-
targeting hexyl triphenylphosphonium (TPP) cation was used as a mitochondrion-localized 
superoxide indicator (Invitrogen, Carlsbad, CA). The fluorescent probe 5-(and-6)-chloromethyl-
2',7'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2-DCFDA; also from Invitrogen) 
was used as a cytosol-localized mitochondrial crisis indicator. As the majority of DCF 
fluorescence relies on cytochrome c release from the mitochondria and cytosolic H2O2 oxidation 
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of cytochrome C (Brömme et al., 2008; Karlsson et al., 2010).  These detection methods were 
used for end point as well as real-time experiments. At the end of the incubation periods for end 
point experiments, cells were washed with Dulbecco’s phosphate buffered saline, containing 
calcium and magnesium (DPBS) and incubated at 37°C, with 4 µM MitoSox Red or 6 µM of 
CM-H2DCFDA in DPBS for 35 and 45 minutes, respectively. After loading of the fluorescence 
probe, cells were washed twice with DPBS. After preloading, cells were dissociated from the 
dishes by adding 1 mL of 10x TrpLe dissociation buffer (Life Technologies, Grand Island, NY) 
for 30 seconds, and after adding 1 mL of DPBS, collected through repeated aspirations and 
ejections. MitoSox fluorescence was measured using an Accuri C6 flow cytometer (BD, Franklin 
Lakes, New Jersey) at an excitation wavelength of 488 and a 585 ± 40 nm emission filter. H2-
DCFDA fluorescence was measured using an excitation wavelength of 488 and a 535 ± 30 nm 
emission filter. The real-time approach will be described separately in addition to being the 
subject of an independent chapter.  
Continuous Real-Time Flow Cytometry Analysis 
To quantify changes in fluorescence on a cell-by-cell basis over the course of minutes to 
hours an apparatus was invented that could be retrofitted to any flow cytometers not operating 
under pressurized conditions like the BD Accuri C6. Briefly, the apparatus consists of an open 
30 mL polypropylene receptacle (vial) surrounded by a water coil jacket, supplied by a heated-
circulating water bath, set to maintain the temperature at 37C. The vessel is sitting on a stir plate 
allowing a rapid dispersion of FA or drugs without interruption, as well as maintaining 
homogeneous cell sampling.  After loading of the fluorescence probe as described in their 
respective method subsection, cells were processed similarly, except for the final addition of 1 
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mL of flow buffer, which consisted of Krebs’s ringer bicarbonate buffer (Sigma-Aldrich Co., St. 
Louis, MO) containing 600 µM fatty acid-free bovine serum albumin, 5% fetal calf serum, 33 
µM Biotin, 17 µM D-Pantothenate, 50 IU/ml penicillin, and 50 µg/ml of streptomycin instead of 
DPBS.  Cells were counted by gating the single cell population in the Forward Scatter (FCS-H) 
versus Side Scatter (SSC-H) density plot. The counted cells were suspended in flow buffer to 
obtain a final concentration of about 1x10
6
 cells in a total volume of 7 mL. The suspended cells 
were transferred into the 30 ml vial. A stir bar was added and rotated at 400 rpm to maintain the 
oxygen tension constant, to quickly distribute the added compounds, and to prevent cell 
clumping. The flow rate was adjusted to have a flow rate of 66 µL/minute and a core size of 22 
µm in order to analyze fluorescence levels from about 2000 cells in the live cell region per 
minute. Baseline fluorescence in each sample was measured for 3-5 minutes prior to the addition 
of 600 µM BSA (basal). After 5 minutes, different compounds were added directly to the 
sample.  
Detection of Lipid Peroxide Formation 
Mitochondrial inner membrane localized lipid peroxidation was assessed using a C11-
BODIPY
581/591 
probe conjugated to a TPP cation moiety (MitoPerOx: Dr. Michael Murphy, 
MRC Mitochondrial Biology Unit; Cambridge, England, UK) (Prime et al., 2012). The reduced 
C11-BODIPY
581/591 
probe has a maximum emission wavelength of ~590 while the oxidized 
product displays a maximum emission wavelength of  ~520 nm in response to lipid peroxidation 
by hydroxyl and peroxy radicals  (Drummen et al., 2004).  Briefly, cells were incubated, at 37°C, 
in DPBS with 150 nM MitoPerOx for 30 minutes. After loading, cells were collected and CRT 
flow cytometry or fluorescent microscopy was performed. For the CRT flow cytometry 
experiments, MitoPerOx was excited at a wavelength of 488 and emission captured through a 
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585 ± 40 nm and 535 ± 30 nm emission filters for the reduced and oxidized form of MitoPerOx, 
respectively. For the microscopy based experiments, cells were washed with 1x PBS and 1 mL 
of flow buffer was added. Following an addition of flow buffer, images were taken at multiple 
time points with an EVOS fluorescent microscope (AMG, a part of life technologies, Grand 
Island, NY) using the GFP light cube, which couples a 470 ± 22 nm excitation and a 525 ± 50 
nm emission filter, as well as the RFP light cube, which couples a 531 ± 40 nm excitation to a 
593 ± 40 nm emission filter.  
Detection of Mitochondrial and Cytosolic H2O2  
H2O2  levels in the mitochondrial or cytosolic compartment were measured using the 
genetically encoded sensors Mito-HyPer (has a mitochondria targeted sequence) or Cyto-HyPer 
(which resides in the cytosol) that encode for a mutated OxyR protein that  is sensitive to 
submicromolar (or physiological) levels of  H2O2 (Belousov et al., 2006; Choi et al., 2001). 
HyPer has an emission of ~516 nm and an excitation of 420 and 500 nm. In the presence of 
H2O2, the excitation peak of  HyPer at ~420 nm decreases proportionally to the increase of the 
excitation peak at 500 nm, allowing for the ratiometric measurement of H2O2.  For the studies, 
measurements of the ~516 nm emission peak was used with a 530± 30 nm emission filter, after 
using an excitation wavelength of 488 only. Cells were plated in six well dishes and grown for 
48 hours before CRT flow cytometry was performed. The cells were lifted as described in the 
CRT flow cytometry subsection and the FA added similarly.  
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Cell Death  
Cell death was measured by Calcein AM and Ethidium Homodimer-1 (Life 
Technologies, Grand Island, NY). Calcein AM is a live cell dye that accumulates in intact cells 
where it acquires a strong green fluorescence upon cleavage by intracellular esterases 
(Papadopoulos et al., 1994). Because intracellular esterase activity is quickly lost as cells die, 
little to no gain in fluorescence occurs in dead or dying cells. Ethidium Homodimer-1 is a dye 
that enters the damaged plasma membrane and interacts with nucleic acids. As Ethidium 
Homodimer-1 interacts with nucleic acids the red fluorescence of the dye increases by 40 Fold, 
indicating dying or dead cells (Papadopoulos et al., 1994). At the end of the 6, 12 or 24 hour FA 
incubation periods, cells were collected and incubated for 15 minutes at room temperature in 
DPBS containing Calcein AM and Ethidium Homodimer 1 at a final concentration of 0.05 µM 
and 4 µM. To detect Calcein AM fluorescence an excitation wavelength of 488 and a 530± 30 
nm emission filter was used. Ethidium Homodimer 1 fluorescence was detected using an 
excitation wavelength of 488 and a 675 ± 25 emission filter. After subtraction of auto-
fluorescence, the live cell region was determined by examining an untreated sample and a 
sample containing only 600 µM BSA. Dead cells were determined by treating a control sample 
with 0.01% Triton-X for 15 minutes. All values for cell death represent the percent of dead cells 
found in the gated region of the cell population of interest.  
Mitochondrial Inner Membrane Permeabilization 
As mentioned in the description of the use of Calcein AM for the identification of live 
cells, Calcein AM enters cells and has access to every compartment. Cobalt is known to quench 
Calcein fluorescence, but since cobalt  does not freely enter mitochondria, Calcein AM 
fluorescence within the mitochondria is not quenched unless there is an increase in membrane 
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permeability (Petronilli et al., 1998). Briefly, cells are incubated with Calcein AM at a final 
concentration of 0.05 µM in DPBS for 30 minutes, followed by 200 µM CoCl2 for 15 minutes. 
Calcein AM fluorescence was measured using an excitation wavelength of 488 and a 535 ±30 
nm emission filter. Mean fluorescence and percent of cells experiencing mitochondrial inner 
membrane permeabilization was determined by histogram plots of Calcein AM after the 
subtraction of auto fluorescence.  
Detection of Changes in the Inner Mitochondrial Membrane Potential  
Changes in inner mitochondrial membrane potential was measured by using the lipohilic 
cationic dye tetramethylrhodamine ethyl (TMRE) ester (Sigma-Aldrich Co) that accumulates in 
direct proportion to the inner mitochondrial membrane potential according to the Nernst 
Equation. Each sample was incubated with 50 nM TMRE in DPBS for 20 minutes at 37
0
C. 
TMRE was measured using an excitation wavelength of 488 and a 585 ±40 nm emission filter. 
Mean fluorescence was determined by histogram plots of TMRE fluorescence after the 
subtraction of auto fluorescence.  
Cellular Respiration Assay 
Approximately 20,000 preadipocytes in growth media without growth factors were 
seeded to each well of Seahorse XF24 plates (Seahorse Bioscience, MA) and grown for 24 hours 
at 37C before treatment with various inhibitors or FA. Four to six hours before the experiments, 
the media was changed to DMEM, containing 5% calf serum, 25 mM Hepes, 10 mM glucose 
and 600 µM FA-free BSA. An hour before FA treatments, inhibitors or their vehicle was added 
to the cells, and then FA were added at various concentrations (0 – 1000 µM) for 24 hours.  At 
the end of the incubation, cells were washed two times with 1 ml of phosphate-buffered saline 
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with magnesium and calcium. Finally, 500 µL of Seahorse XF-DMEM medium containing 10 
mM glucose and 2 mM sodium pyruvate was added to the cells. Cellular respiration was 
measured as described previously by Herscovitch et. al., (Herscovitch et al., 2012) with the 
following slight modifications determined to be optimal in preliminary experiments. First, the 
measurement cycle consisted of 1 minute mix, 1 minute wait and three minutes measurement. 
Second, three basal rate measurements were taken, three after oligomycin injection, three after 
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) injection and three after 
Rotenone injection. Drugs were delivered through the ports at final concentrations of 1 µM for 
oligomycin, 500 nM for FCCP and 1 µM for Rotenone. Each of the three independent 
experiments were performed in triplicate.  
NAD+ and NADH Levels 
Following FA exposure, cells were washed twice with PBS. NAD+ levels were 
determined using a NAD+/NADH cell-based assay kit as described in the manual (Cayman 
Chemical, Ann Arbor, MI). After washing, cells were lysed, centrifuged and the supernatant was 
used to measure NAD+ and NADH levels. In this assay, alcohol dehydrogenase converts ethanol 
to acetoaldehyde and yields NADH from the NAD+ present in the supernatant. After NADH is 
formed, it reduces the tetrazolium salt substrate (WST-1) into a highly colored formazan dye that 
absorbs at the 450 nm wavelength.  An Infinite 200 Pro Series plate reader was used to quantify 
absorbance. As more than 95% of the NAD in cells is oxidized this assay is essentially a NAD+ 
assay. 
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ATP Determination 
Following FA exposure, cells were washed twice with PBS, and ATP was extracted by 
using the boiling water extraction method (Yang et al., 2002). Following extraction, ATP levels 
were determined using an ATP determination kit, as described by the supplier (Life 
Technologies). An Infinite 200 Pro Series plate reader was used to quantify luminescence. 
Statistical Analysis  
Statistical analysis was performed with PRISM (GraphPad Software, San Diego, CA) 
version 5.00 for Windows. Differences between FA concentrations, 600 µM BSA and/or 
pretreatment with MitoTempo, Etomoxir, Carnosine, Cyclosporin A or Nicotinamide were 
assessed by a one-way ANOVA with a Tukey’s multiple comparison test. All values are reported 
as + SD. In all cases, a P value of less that 0.05 was used to indicate statistical significance 
between conditions. 
Results 
24 Hour exposure to fatty acids in human preadipocytes leads to cell death  
Conditionally immortalized human subcutaneous adipose tissue preadipocytes were 
treated with a physiological mixture of FA in a concentration range and a FA to albumin ratio 
that resembles the physiological state within adipose tissue. Preadipocytes were treated with 
increasing concentrations of FA for 6, 12, 24 hours and changes in fluorescence of Calcein AM 
and Ethidium Homodimer 1 were examined using flow cytometry or microcopy). Figure 5A 
illustrates two representative flow cytometry dot-blots comparing the BSA control to 1000 µM 
FA-treated cells. Figure 5B illustrates two representative microscopy observations from the same 
comparison. Figure 5C is the average of three independent experiments that shows that it takes 
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24 hours of constant exposure to FA and concentrations of 800 µM FA and 1000 µM FA to 
observe a significant amount of cells death. No difference in cell death among the different FA 
concentrations was observed at the 6 and 12 hour time point (Figure 5C).  
To test the hypothesis that FA entry into the mitochondria and/or ROS production could 
cause cell death, cells were pretreated for 10 minutes with 10 µM Etomoxir, a carnitine palmitoyl 
transferase I inhibitor that blocks entry of fatty acyl CoA into the mitochondria or 10 µM 
MitoTempo, a mitochondrial specific superoxide and alkyl radical scavenger. Pretreatment with 
Etomoxir or MitoTempo, followed by 1000 µM FA exposure, resulted in a significant decrease 
in cell death compared to 1000 µM FA alone (Figure 5D), suggesting that FA entry into the 
mitochondria and ensuing superoxide or alkyl radical production was the main source of cell 
death.  Since retention of Ethidium Homodimer 1 occurs in the late stages of cell death, 6 and 12 
hours of constant FA exposure followed by 18 and 12 hours of 600 µM BSA respectively, was 
investigated. No change in cell death at 24 hours after treating for 6 or 12 hours was observed 
(data not shown) indicating that FA exposure only caused cell death after 12 hours of constant 
FA exposure. Interestingly, the addition either Etomoxir or MitoTempo two hours after the onset 
of the FA treatment totally abrogated their protective effects (Figure 5E).  
Fatty acids cause a transient and a delayed increase in superoxide and H2O2 within the first 
hour of exposure 
Once an elevation in superoxide or alkyl radicals occurs, the resulting oxidation of 
proteins, lipid and/or nucleotides can lead to cellular dysfunction, and ultimately cell death 
(Girotti, 1998). To observe if cell death was accompanied or preceded by an increase in 
mitochondrial and cytosolic oxidation, changes in the mean fluorescence of MitoSox Red and 
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H2DCFDA was measured. At the 24 hour time point a statistically significant increase in the 
mean fluorescence of H2DCFDA (Figure 6A and C) and MitoSox Red (Figure 6B and D) was 
observed suggesting that mitochondrial and cytosolic compartments were in the presence of an 
oxidative environment. Pretreatment with Etomoxir or MitoTempo prevented the increase in 
CM-H2DCFDA (Figure 6C) and MitoSox Red (Figure 6D) fluorescence induced by 24 hours 
exposure to 1000 µM FA, suggesting that FA entry into the mitochondria and subsequent 
superoxide or alkyl radical production were the cause of the increased oxidative environment at 
24 hours. To confirm that FA exposure initiated a sustained increase in ROS and oxidative 
environment, MitoSox Red and H2DCFDA fluorescence at 3 and 12 hours following FA 
exposure were measured. Surprisingly, no change in MitoSox Red or H2DCFDA fluorescence 
was observed at the 3 or 12 hour time points (Figure 6A and B).  
The greatest protective effect of Etomoxir or MitoTempo pretreatment against cell death 
was seen during the first hour of FA exposure.  However, no changes in MitoSox or H2DCFDA 
fluorescence were observed after 3 hours of FA exposure. Therefore, we directly investigated the 
existence of a transient increase in mitochondrial superoxide following the addition of FA. To 
characterize such a rapid changes in superoxide levels, preadipocytes were preloaded with 
MitoSox Red and changes in fluorescence measured using continuous real time (CRT) flow 
cytometry, a method that we recently developed (Chapter 3). Representative traces demonstrate 
that MitoSox fluorescence rapidly increases upon FA exposure. At the end of one hour, 57.9 ± 
2.6 %  of preadipocytes treated with 1000 µM FA had high MitoSox Red fluorescence compared 
to just 14.03 ± 3.7 % of the cells in 600 µM BSA (Figure 7B). Since MitoSox Red is not 
reversible once oxidized, no oscillations in fluorescence could be observed once reaching the 
fluorescent plateau. Therefore, cells were treated with FA for 0, 15, 30, 45 or 60 minutes, 
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followed by intermediate loading of MitoSox Red at -15, 0, 15, 30, 45 or 60 minutes. 
Comparison of 1000 µM FA versus 600 µM BSA revealed a waxing and waning of MitoSox 
Red fluorescence that occurred within 60 minutes of FA exposure (Figure 7C). Pretreatment of 
Etomoxir or MitoTempo followed this increase in MitoSox Red mean fluorescence (Figure 7C). 
To examine H2O2 production, cells were transfected with pHyPer, a genetically encoded 
reversible H2O2-selective fluorescent sensor, that is capable of detection of intracellular H2O2 in 
the physiological or nanomolar range (Belousov et al., 2006). cells were transfected with pHyPer 
Mito. Since H2O2 production is a product of the dismutation of superoxide, CRT flow cytometry 
was used to characterize rapid (second to minutes) changes in pHyPer fluorescence. Figure 8A 
illustrates a transient elevation in the number of events with a higher pHyPer Mito fluorescence 
following 1000 µM FA (Red dots) exposure versus 600 µM BSA (black dots). Single time point 
analysis of pHyPer Mito fluorescence revealed an increase and decrease in pHyPer Mito 
fluorescence within the first 60 minutes of FA exposure (Figure 8B) that could be blocked by 
pretreatment of Etomoxir or MitoTempo (Figure 8B).  
Mitochondrial lipid peroxidation occurs within two hours of exposure to fatty acids  
Mitochondrial lipid peroxidation, which is a free radical-mediated degradation process by 
which lipids are oxidized leading to alteration of their structure and functions (Girotti, 1998). To 
examine mitochondrial lipid peroxidation, CRT flow cytometry and fluorescent microscopy of 
the fluorescent probe MitoPerOx, which in response to lipid peroxidation shifts its fluorescence 
from ~590 nm to ~520 nm, were measured (Prime et al., 2012). Figure 9A shows a 
representative dot blot of the shift in fluorescence after treatment with 1000 µM FA over a 150 
minute timespan.  Figure 9B displays microscopic imaging of a similar experiment where 600 
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µM BSA and 1000 µM FA are compared with respect to MitoPerOx oxidation. These images 
were obtained by merging the fluorescence at each wavelength observed after 1 hour of exposure 
to either 1000 µM FA or 600 µM BSA. Analysis of the mean fluorescence of MitoPerOx 
following treatment with 600 µM BSA or 1000 µM FA at 0, 30, 60, 90, 120 and 150 minutes 
showed that the ratio of 530/585 mean fluorescence reached a plateau after 120 minutes of 1000 
µM FA exposure (Figure 9C). Figure 9C also shows the increase in MitoPerOx green 
fluorescence was prevented by pretreatment with MitoTempo or 10 µM carnosine. Carnosine is a 
compound identified as a scavenger of both α,β-unsaturated aldehydes such as hydroxynonenal 
or acrolein and dialdehydes like malondialdehyde or glyoxal that prevents peroxidation as well 
as carbonylation of lipids (Aldini et al., 2006; M. Y. Kim, Kim, Kim, Choi, & Lee, 2011). 
Endpoint analysis, in which MitoPerOx was incorporated into the cells during FA exposure, 
confirmed the absence of active lipid peroxidation at 3, 6 or 12 hours after the addition of 1000 
µM FA (Figure 9D). 
Entry of fatty acids into the mitochondria and subsequent increase in ROS leads to 
mitochondrial crisis  
Although transient increases in mitochondrial superoxide, H2O2 and lipid peroxidation 
occurred within hours of FA exposure, the link between transient increases in mitochondrial 
ROS and cell death was unclear.  One potential hypothesis was that the secondary phase of ROS 
accumulation and cell death was a consequence of a loss in mitochondrial fitness (i.e. the ability 
of the mitochondrion to maintain equilibrium between substrate availability versus substrate 
utilization) that manifested into mitochondrial crisis (i.e. a state of the mitochondrion 
characterized by a unrecoverable loss in mitochondrial respiration, inner mitochondrial 
membrane potential and ATP synthesis). To establish the time course of the possible effects of 
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FA on the respiratory capacity, the oxygen consumption rate (OCR) was measured in real-time 
using respirometry. As shown in Figure 10A, the two concentrations of FA that increased ROS 
and cell death, also significantly altered respiration. Compared to the 600 µM BSA control 
condition, OCR was significantly decreased after 10 hours of FA to 1000 µM FA and by 14 
hours at the concentration of 800 µM, indicating that changes in mitochondrial respiration 
occurred well before any observed cell death. Next, the ability of increasing FA concentrations to 
decrease mitochondrial inner membrane potential was investigated. Surprisingly, Figure 10 B 
shows that  tetramethylrhodamine ethyl (TMRE) fluorescence, a cationic dye that collects in the 
mitochondria in direct proportion to the mitochondrial inner membrane potential, was decreased 
24 hours after the addition of 800 or 1000 µM of FA, but not after 3 or 12 hours.  As with ROS 
production and cell death, loss of OCR and inner mitochondrial membrane potential could be 
prevented by pretreatment with Etomoxir or MitoTempo (Figure 10C and D).  
The mitochondrial inner membrane potential, or more accurately the mitochondrial inner 
membrane proton gradient, is a driving force for multiple functions including ATP and NADPH 
synthesis (Brand & Nicholls, 2011).  Therefore, ATP levels were measured every 2 hours for 20 
hours (Figure 10 E). As shown in Figure 10E, drops in ATP levels occurred well ahead of 24 
hours, with a statistically significant loss in ATP levels occurring between 12 to 14 hours with 
1000 µM FA and 16 to 18 hours at 800 µM FA. The observed decrease in ATP levels occurred 
about 2 hours after the observed decrease in OCR. For ATP production to occur, reducing 
equivalents, such as NADH, must pass their electrons to the electron transport chain (ETC) to 
generate a proton motive force that can drive ATP synthase to make ATP (GM, 2000). NAD
+
 
and NADH levels were measured every 2 hours up to 20 hours. Interestingly, NAD
+
 and NADH 
levels were significantly decreased within 8 hours of 1000 µM and 12 to 14 hours of 800 µM FA 
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exposure. The drop in NAD
+
 and NADH preceded the decrease in OCR by about 2 hours (Figure 
10F). Pretreatment with either Etomoxir or MitoTempo prevented the decrease of both NAD
+
 
and NADH and ATP measured at 18 and 24 hours respectively (Figure 10H and I) indicating that 
the transient increase in ROS was the triggering event in NAD
+
 and NADH and ATP loss.  
Opening of the mPTP can cause the mitochondrial membrane to become permeable to 
any molecule less than 1.5 kDa, leading to loss of inner mitochondrial membrane potential and 
exit and potential degradation of NAD+ (P Schönfeld & Bohnensack, 1997). To look at the 
opening of the mPTP, preadipocytes were stained with Calcein AM in the presence of CoCl2. 
Calcein AM will enter both the cytosol and mitochondria, while CoCl2 will reside only within 
the cytosol and will quench cytosolic Calcein AM fluorescence (Petronilli et al., 1998). Upon 
opening of the mPTP, CoCl2 can enter and quench mitochondrial Calcein AM fluorescence 
(Petronilli et al., 1998).  The percentage of cells with a lower Calcein AM fluorescence, 
indicative of mPTP opening, was statistically significant in 1000 µM and 800 µM FA at the 12 
and 24 hour time point compared to 600 µM BSA (Figure 10I). Pretreatment with Etomoxir or 
MitoTempo prevented the increase in the number of cells that had lower Calcein AM (Figure 
10J). Together these data suggest that transient increases in ROS leads to a loss of mitochondrial 
fitness as observed by decreases in OCR, inner mitochondrial membrane potential, ATP, NAD
+
 
and NADH and opening of the mPTP. 
Nicotinamide supplementation prevents both the loss or mitochondrial fitness and cell death  
Of all the different mitochondrial readouts examined, decreases in NAD
+
 + NADH levels 
occurred earliest. To test if loss of NAD
+
 and NADH was one of the primary triggers for loss of 
mitochondrial fitness, nicotinamide was added to cells for 30 minutes prior to FA exposure. 
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Decreases in OCR, inner mitochondrial membrane potential, ATP and NAD
+
 and NADH were 
prevented by pretreatment with 40 µM nicotinamide (Figure 11A, B, C and D). Although 
nicotinamide supplementation prevented the deleterious effects brought on by 1000 µM FA 
exposure, the percentage of cells with open mPTP was only partly reduced (Figure 11E). 
Examination of MitoSox Red and CM-H2DCFDA fluorescence at 24 hours revealed that 
nicotinamide supplementation also prevented the delayed oxidative stress phase (Figure 11F and 
G) and the cell death that was associated with 1000 µM FA treatment (Figure 11H).  
As alluded to above, one possible explanation for depletion of NAD
+
 and NADH levels is 
opening of the mPTP. Pretreatment with 10 µM Cyclosporin A, which interacts with cyclophilin 
D to prevent formation of the mPTP did not prevent the decrease in NAD
+
 and NADH induced 
by 1000 µM FA (Figure 11J).  
Discussion 
Although the effects of individual FA on preadipocytes have been studied (Guo et al., 
2007), none have exposed human preadipocytes to a FA mixture that resembles the physiological 
state of adipose tissue.  The novel FA mixture used in this study included the four main FA: 
oleate, linoleate, palmitate and stearate. The relative percentage of each FA within each total 
concentration was kept constant, as it has been shown the percentage of each FA is independent 
of increasing or decreasing FA levels  (Mittendorfer et al., 2003). Although the FA mixture 
accounted for 95% of the FA found in circulation, the other 5%, which includes myristate, 
polyunsaturated FA, etc. may have an impact on preadipocyte function. For example, 3T3-L1 
adipocytes treated for 7 days with 250 µM myristate increased expression of inflammatory 
factors such as MCP-1 (Yeop Han et al., 2010). Furthermore, 25 µM docosahexaenoic acid 
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(DHA) has been shown to increase apoptosis and inhibit differentiation of 3T3-L1 adipocytes (H. 
K. Kim, Della-Fera, Lin, & Baile, 2006). Although these results would suggest that additional 
FA would make our FA mixture more toxic, this may not be the case as both studies used a FA 
to albumin ratio greater than 4:1 (H. K. Kim et al., 2006; Yeop Han et al., 2010) . In circulation, 
FA to albumin ratios rarely exceeds 1:1 except during prolonged exercise, fasting, or locations 
within the adipose tissue depot(Curry et al., 1999; Yamazaki et al., 2005).  For this study, FA 
was conjugated to 600 µM BSA to maintain a ratio below or around 1:1. Despite mimicking the 
physiological environment with respect to FA, limitations exist. One major limitation is that 
preadipocytes are not exposed to a single dose of FA, but rather constant fluctuations of FA, 
glucose and insulin throughout a 24-hour time period (Tahiri et al., 2007). Nevertheless, even 
with a single dose of FA, increases in ROS and lipid peroxidation occurred, suggesting that 
preadipocytes, although within the adipocyte lineage, are a target for lipotoxicity.  
In this study, for cell death to occur, preadipocytes must experience a loss of 
mitochondrial fitness. Interestingly, the loss of mitochondrial fitness appears to occur through 
transient rather than sustained increases in superoxide, H2O2, and lipid peroxidation during the 
first 1-3 hours of FA exposure that primes preadipocytes for death.  Although the initial spike in 
ROS ultimately leads to cell death, preadipocytes still had to be exposed for more than 12 hours 
for death to occur. One possible explanation is that the initial influx of FA into the mitochondria 
causes an increase in ROS above the buffering capacity. Once the equilibrium of FA in and 
outside the preadipocyte establishes, the buffering capacity of the cell is able to return ROS 
levels back to the basal state. Although the elevation of ROS above the buffering capacity 
subsides within an hour, oxidation of processes that lead to NAD
+
 and NADH depletion have 
already been initiated. Although NAD
+
 and NADH loss is observed as soon as 8 hours, it may 
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take more than 12 hours to pass the threshold that leads to an effect on mitochondrial fitness and 
ultimately cell death. Furthermore, by replacing FA with 600 µM BSA at the 12 hour time point 
the need of NAD
+
 and NADH for FA β-oxidation and respiration in the mitochondria may have 
been reduced. For both Cyclosporin A and Carnosine, limiting opening of the mPTP and 
reducing the toxic effect of lipid peroxides on mitochondrial function may delay, rather than 
prevent the detrimental effects of NAD
+
 and NADH depletion, as cell death was observed after 
48, but not 24 hours of FA exposure. 
In addition to loss of NAD
+
 and NADH, a loss in mitochondria fitness was observed. For 
mitochondria, once the mPTP is in a constant open state, disruption of the inner mitochondrial 
membrane, loss of respiration, outer membrane permeabilization and mitochondrial swelling can 
occur (Gottlieb, Armour, Harris, & Thompson, 2003; Mather & Rottenberg, 2001). Although 
opening of the mPTP was observed at 12 hours, this did not translate to a loss in inner 
mitochondrial membrane potential. However, the sensitivity of TMRE to change in response to 
mPTP opening is lower than that of Calcein AM, since a 5-fold increase in the number of cells 
with lower Calcein AM fluorescence did not result in a similar change in TMRE fluorescence 
after 24 hour exposure to 1000 µM FA. Furthermore, since all of the FA concentrations and flow 
experiments were used with a threshold and gate based on 600 µM BSA, an underestimation of 
FA effects could have occurred, since dying cells would have shifted out of the live region. 
Nevertheless, time course evaluation did show decreases in the OCR, ATP and NAD
+
 and 
NADH before any measurable death was observed, suggesting that the loss of mitochondrial 
fitness was not dependent on cell death.  
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 In summary, preadipocytes are susceptible to FA through transient (1-2 hours) increases 
in ROS that lead to depletion of NAD
+
 and NADH and ATP, reduction of OCR, opening of the 
mPTP, decrease of the mitochondrial inner membrane potential, and ultimately to cell death. The 
initial increase in ROS is initiated through FA entry into the mitochondria and superoxide 
production. Despite FA causing a delayed increase in cytosolic ROS it does not appear to cause 
cell death. Finally, nicotinamide supplementation prevented the loss of mitochondrial fitness that 
was associated with FA exposure, suggesting that nicotinamide could provide protection against 
the ill effects of FA.  
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Figure 5. Fatty acids cause cell death after 24 hours of exposure 
Preadipocytes were exposed to FA for 24 hours. Flow cytometry dot plots (A) and microscopy 
(B) analysis of Calcein-AM vs. Ethidium Homodimer 1 fluorescence demonstrates a shift in live 
cells (green) to dead cells (red) at 1000 µM FA concentrations. In addition to 1000 µM FA, 800 
µM FA treated cells also had a significant increase in the percentage of dead cells at 24 hours, 
but not at 6 or 12 hours (C). Increases in the percentage of dead cells could be prevented by 
pretreatment with Etomoxir or MitoTempo followed by 1000 µM FA exposure, indicating that 
FA entry and superoxide and/or alkyl radical production was the cause of cell death (D). To test if 
the initial hour was important in preventing cell death, pretreatment or post-treated either 1 or 2 
hours after FA exposure with Etomoxir and MitoTempo was performed (E). Post-treatment with 
either Etomoxir or MitoTempo restored the elevation in the percentage of cell death that was 
associated with 1000 µM FA.   Percentage of dead cells and mean fluorescence is expressed as + 
SD (n=three independent experiments for C, D and E). * P < 0.05 when compared to 600 µM 
BSA. + P < 0.05 when compared to 1000 µM FA. 
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Figure 6. Fatty acids cause an increase in oxidative stress at 24, but not 3 and 12 hours 
Preadipocytes were exposed to FA for 24, 12 and 3 hours. Flow cytometry histograms of the 24, 
12 and 3 hour time point of CM-H2DCFDA (A) or MitoSox Red (B) showed only increases in 
1000 µM FA at 24 hours (Shaded Gray =Unstained, Solid Line=600 µM BSA and Dotted 
Line=1000 µM FA). Measurements of mean fluorescence at 24 hours across the FA 
concentration dose range show increases in CM-H2DCFDA (C) or MitoSox Red (D) 
fluorescence when treated with 800 and 1000 µM FA. Pretreatment with either Etomoxir or 
MitoTempo followed by 1000 µM FA exposure prevented the increase in mean fluorescence of 
CM-H2DCFDA (C) or MitoSox Red (D). Mean fluorescence is expressed as + SD (n=three 
independent experiments for C and D). * P < 0.05 when compared to 600 µM BSA. + P < 0.05 
when compared to 1000 µM FA. 
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Figure 7. Fatty acids cause a transient increase in mitochondrial superoxide 
Preadipocytes were preloaded with MitoSox Red and CRT flow cytometry was performed. After 
an initial baseline of 5 minutes with 600 µM BSA, FA were added and changes in MitoSox Red 
fluorescence was measured over time (A). At the end of 1 hour, the percent of cells with 
MitoSox Red fluorescence above baseline was counted (B). To determine the period at which 
increases in superoxide occur, preadipocytes were preloaded with MitoSox Red at different time 
points after the addition of FA. Transient increases in MitoSox Red fluorescence occurred within 
the first 60 minutes of FA exposure (C). The associated increase in MitoSox Red fluorescence 
was prevented by pretreatment with Etomoxir or MitoTempo (C). Arrows indicate the addition 
of FA. Percent of cells, AUC and mean fluorescence is expressed as + SD (n=three independent 
experiments for B C D). * P < 0.05 when compared to 600 µM BSA. + P < 0.05 when compared 
to 1000 µM FA. 
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Figure 8. Fatty acids cause a transient increase in mitochondrial H2O2 levels 
Preadipocytes were transfected with the genetically encoded H2O2 sensor pHyPer Mito. Changes 
in pHyPer-Mito fluorescence upon exposure to 600 µM BSA(Black) or 1000 µM FA (Red) were 
measured over time using CRT flow cytometry and plotted in GraphPad Prism (A). Like changes 
in superoxide, analysis of mean fluorescence at a single time point revealed that increases in 
H2O2 occurred within 60 minutes (B), and could be prevented by pretreatment with Etomoxir or 
MitoTempo (B). Mean fluorescence is expressed as + SD (n=three independent experiments for 
C and F). * P < 0.05 when compared to 600 µM BSA.  
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Figure 9. Lipid peroxidation occurs within the first 3 hours of exposure to fatty acids 
Preadipocytes were preloaded with MitoPerOx 30 minutes prior to performing CRT flow 
cytometry. MitoPerOx is a ratiometric dye that upon lipid peroxidation will shift its emission 
from 585/40 to 535/30 (A). Microscopy of preadipocytes treated with 600 µM BSA or 1000 µM 
FA for 1 hour shows an increase in emission of MitoPerOx with 1000 µM FA (B). To see if lipid 
peroxidation was occurring in a transient fashion, MitoPerOx fluorescence was measured at 
different intervals during the 150 minutes of FA exposure and revealed a statistically significant 
increase in MitoPerOx fluorescence (C) with 1000 µM FA, which could be prevented by 
pretreatment with MitoTempo or Carnosine (D). Like MitoSox Red and CM-H2DCFDA, no 
change in the ratio of 530/585 was observed after 3 hours of FA exposure, suggesting that lipid 
peroxidation, like superoxide and H2O2 is transient. AUC and mean fluorescence is expressed as 
+ SD (n=three independent experiments for C and D). * P < 0.05 when compared to 600 µM 
BSA. + P < 0.05 when compared to 1000 µM FA. 
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Figure 10. Exposure to fatty acids cause an increase in mitochondrial crisis through loss of 
respiration, inner mitochondrial membrane potential, ATP, NAD+ and NADH and opening 
of the mitochondrial permeability transition pore 
Preadipocytes exposed to FA have a decrease in OCR over the course of 20 hours (A). Inner 
mitochondrial membrane potential as assessed by TMRE fluorescence revealed a decrease in the 
mean fluorescence after 24 hours, but not at 3 and 12 hours following FA exposure (B). Along 
with a decrease in OCR, ATP (C) and NAD
+
 + NADH (D) levels were also decreased when 
exposed to 1000 µM FA over the course of 20 hours. Preadipocytes also had an increase in the 
percentage of cells with low Calcein AM fluorescence at 12 and 24 hours of FA exposure, 
suggesting that opening of the mPTP was occurring. Pretreatment with Etomoxir or MitoTempo 
followed by 1000 µM FA exposure prevented the loss of OCR (F), inner mitochondrial 
membrane potential (G), ATP (H), NAD
+
 + NADH (I) and mPTP opening (J). (For A, C and D: 
Black=600 µM BSA, Green=200 µM, Dark Green=400 µM FA, Orange=600 µM FA, Red=800 
µM FA, Dark Red=1000 µM FA). Time course experiments and 24 hour measurements are 
expressed as + SD (n=three independent experiments for A, B, C, D, E, F, G, H, I and J). * P < 
0.05 when compared to 600 µM BSA. + P < 0.05 when compared to 1000 µM FA. 
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Figure 11. Nicotinamide supplementation prevents the loss of mitochondrial fitness, 
oxidative stress and cell death associated with fatty acids at 24 hours 
Preadipocytes were supplemented with 40 µM nicotinamide for 30 minutes prior to FA 
exposure. Nicotinamide pretreatment followed by 1000 µM FA, prevented the loss of OCR (A) 
inner mitochondrial membrane potential (B), ATP (C), NAD
+
 and NADH (D) and mPTP 
opening (E). Nicotinamide pretreatment also prevented the increase in CM-H2DCFDA (F) and 
MitoSox Red (G) fluorescence, as well as cell death (H) at 24 hours. Since loss of NAD
+
 and 
NADH can occur through opening of the mPTP cells were pretreated with cyclosporin A and a 
decrease in mPTP opening was observed (I). Despite preventing the opening of the mPTP, 
cyclosporin A did not prevent the loss of NAD
+
 and NADH that was associated with 1000 µM 
FA exposure (J). OCR, mean fluorescence, ATP, NAD
+
 + NADH and percentage of cells is 
expressed as + SD (n=three independent experiments for A, B, C, D, E, F, G, H, I and J). * P < 
0.05 when compared to 600 µM BSA. + P < 0.05 when compared to 1000 µM FA. 
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CHAPTER 5:  SIRTUIN-1 ACTIVITY-DEPENDENT ANTIOXIDANT GENE 
EXPRESSION IN SUBCUTANEOUS ADIPOSE TISSUE CORRELATES TO INSULIN 
SENSITIVITY IN OBESE INDIVIDUALS 
Carlyle Rogers, Barbara Davis and Jacques Robidoux 
1
Department of Pharmacology and Toxicology and 
2
The East Carolina Diabetes and Obesity 
Institute, East Carolina University, Greenville, North Carolina. 
Abstract 
Adipose tissue dysfunction has been implicated as a major risk factor in the development 
of obesity-associated metabolic abnormalities such as systemic insulin resistance. One 
hypothesis as to why adipose tissue failure occurs is the inability of cells within adipose tissue to 
adapt and survive in an obesogenic environment. One mechanism that may explain why adipose 
tissue failure occurs is that the mitochondria are unable to sustain the reducing pressure of 
chronic nutrient energy imbalance. Therefore, the gene expression of antioxidant proteins, with 
an emphasis on mitochondrion-located enzymes, was measured from adipose tissue collected 
from thirty-two women covering a wide range of body mass indices and insulin sensitivity. Of 
the antioxidant genes measured, the expression of superoxide dismutase 2 (SOD2), 
peroxiredoxin 3 (PRDX3), thioredoxin reductase 2 (TXNRD2) and glutathione peroxidase 1 
(GPX1) was lower in insulin-resistant obese individuals.  Additionally, antioxidant gene 
expression and insulin sensitivity correlated positively with expression of the deacetylase sirtuin 
1 (SIRT1), and the nuclear transcription factor forkhead member of the class O 1 (FOXO1), 
which could serve as part of the signaling pathway that links changes in nutrient availability, 
including fatty acids (FA), to antioxidant gene expression.  In preadipocyte culture, FA exposure 
caused an increase in deacetylation of FOXO1 that was dependent on the formation of 
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mitochondrial superoxide or alkyl radicals. Furthermore, the expression of dominant negative 
SIRT1 and FOXO1 caused an exaggeration in FA-induced cell death. All together, these findings 
suggest that lower expression of SIRT1-FOXO1-regulated antioxidant gene expression is linked 
to insulin resistance and preadipocyte susceptibility to FA. 
Introduction 
Obesity has long been known to be an inherent risk factor for metabolic syndrome, 
diabetes and cardiovascular disease, with many of the associated metabolic changes being linked 
to the progression of insulin resistance and hyperinsulinemia (P. J. Anderson et al., 1997; Baik et 
al., 2000; McLaughlin, Abbasi, Lamendola, & Reaven, 2007). Despite the inherent risk of 
obesity, several studies have identified a subset of obese individuals, who despite an elevated 
body mass index (kg/m
2
), remain relatively free from the perils of insulin resistance (Karelis et 
al., 2005; Klöting et al., 2010; Stefan et al., 2008). In the literature this subgroup of obese 
individuals has been identified as insulin-sensitive obese (ISO), and in addition to having normal 
glucose and insulin levels, present with lower plasma triglycerides, higher HDL cholesterol, and 
lower pro-inflammatory markers than insulin-resistant obese (IRO) and Type 2 Diabetic (T2DM) 
individuals (Brochu et al., 2001; Klöting et al., 2010). Despite a preponderance of evidence for 
improvements in physiological parameters, the exact mechanism that safeguards ISO individuals 
against obesity-related metabolic complications is unclear.  
Although obesity can be classified as a necessary expansion of the body’s adipose tissue 
to store an overabundance of calories, if caloric intake outpaces adipose tissue expansion an 
increase in the level of circulating non-esterified fatty acids (NEFA) can occur  (Frayn, 2002; J. 
Smith et al., 2006). Consequently, an elevation of NEFA has been suggested as a risk factor for 
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ectopic fat accumulation and deterioration of glucose tolerance (Boden, 2008; Charles et al., 
1997). Despite the recognized risk of NEFA on non-adipose tissue, the impact of elevated NEFA 
within adipose tissue has been overlooked since adipocytes possess the capability to increase the 
esterification rate of FA. In the context of obesity, however, the capacity of adipocytes to store 
FA may actually be lower (since it was found that a population of adipocytes that are slightly 
larger in size than preadipocytes but smaller than mature adipocytes are unable to store 
triacylglycerol) (McLaughlin, Sherman, et al., 2007). If the ability of adipocytes to esterify FA is 
reduced, then elimination of FA by oxidation may serve as the only protective mechanism 
against elevated circulating NEFA.  
For adipocytes, and other cell types within adipose tissue such as preadipocytes and 
macrophages, FA oxidation serves to increase levels of NADH and FADH2 for the synthesis of 
ATP (GM, 2000). In the absence of a concomitant increase in ATP demand, the likelihood of 
one-electron reduction of  oxygen to form superoxide is increased (P Schönfeld & L Wojtczak, 
2008). If superoxide or its byproduct (such as H2O2) is elevated above the antioxidant buffering 
capacity of the cell, formation of toxic by-products such as hydroxyl radicals and lipid peroxides 
can occur, leading to damage of mitochondrial components (Girotti, 1998; Murphy, 2009). 
Therefore, up-regulation of mitochondrial antioxidant genes may serve to protect against the 
elevation in ROS brought about by increased FA oxidation.  
The purpose of the present scientific study was to investigate whether gene regulation 
associated with mitochondrial ROS detoxification differs in subcutaneous adipose tissue from 
insulin-sensitive non-obese (ISNO), ISO, IRO and T2DM individuals.  
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Materials and Methods 
Subjects 
All 32 subjects were women from eastern North Carolina, recruited through participating 
physicians performing abdominal surgery at Vidant Medical Center, and all subjects had given 
informed written consent. Subjects for this study were previously used in Rogers et al. to 
compare EGF Receptor (ERBB1) abundance in adipose tissue to markers of adipogenesis and 
proliferation (Rogers et al., 2012a). Their ages ranged from 25 to 61 years and their body mass 
indices (BMI) ranged from 20.7 to 54.7 kg/ m2. The protocol was approved by the East Carolina 
University Institutional Review Board (Appendix 1). All subjects were undergoing 
hysterectomies and were not taking drugs that could affect lipid or glucose homeostasis. BMI 
was calculated from body mass and height recorded at the time of surgery to the nearest 0.5 kg 
and centimeter, respectively. Fasting glucose was quantified from blood collected the day of the 
surgery using the 2300 Stat Plus System (Yellow Springs Instruments, Inc., Yellow Springs, 
OH). Insulin was quantified using the Beckman-Coulter Access Immunoassay System 
(Beckman-Coulter, Fullerton, CA). Abdominal subcutaneous adipose tissue (outside the fascia 
superficialis) was chosen because it constitutes the primary site of fatty acid storage and release, 
and hence would likely be a location where turnover is critical to maintaining fatty acid 
homeostasis (Koutsari & Jensen, 2006). The tissue was immediately frozen in liquid nitrogen, 
transported to the laboratory, and stored at -80
0
 C. For comparison purposes, the subjects were 
subdivided into four groups:  the insulin-sensitive lean (ISNO) [BMI_30 kg/m
2
, homeostasis 
model of assessment for insulin resistance (HOMA-IR) _2.6 (actual highest value was 1.7), 
fasting insulin 10 _IU/ml, and fasting glucose_110 mg/dL]; the insulin-sensitive obese (ISO) 
(BMI_30 kg/m
2
, HOMA-IR _2.6, fasting insulin _10 _IU/mLl, and fasting glucose _110 mg/dl); 
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the insulin-resistant obese (IRO) [BMI _30 kg/m
2
, HOMA-IR _2.6 (actual lowest value was 3.0), 
fasting insulin _10_IU/mL, and fasting glucose_126 mg/dL], and the T2DM (fasting glucose 
>126 mg/dL on two occasions). The HOMA-IR cutoff of 2.6 was determined from our data bank 
of 38 lean individuals with normal glucose tolerance based on the commonly used 75th 
percentile, and it is in line with previously reported cutoffs (Ascaso et al., 2003). For some 
comparisons, the subjects from the first and fourth quartiles were compared with respect to 
insulin sensitivity, regardless of their body weight. Analysis of data from 81 subjects for which 
there were both HOMA-IR and iv glucose tolerance tests, minimal model values established that 
the first and last quartiles of HOMA have a sensitivity of 0.9 to identify subjects belonging to the 
last and first tertiles of SI, respectively. These are more stringent HOMA-IR cutoffs than the 
above-described insulin-sensitive and insulin-resistant cutoffs. For other comparisons, we 
compared the subjects from the first and fourth quartiles with respect to SIRT1 and FOXO1 
protein levels.  
Cell Culture 
XA15A1 human preadipocytes (Lonza Walkersville, Inc., Walkersville, MD) were 
cultured as described in Skurk et al.,(Skurk et al., 2007) using Dulbecco's modified Eagle's 
medium: F12 (DMEM:F12; Mediatech, Manassas, VA) with 10% calf serum, 15 mM glucose, 
33 µM biotin, 17 µM D-pantothenate, 100 nM insulin, and 10 nM hydrocortisone (all from 
Sigma Aldrich), 1 nM epidermal growth factor and 1 nM basic fibroblast growth factor (Gemini, 
West Sacrameto, CA).  This medium also contained 50 IU/ml penicillin, 50 µg/ml of 
streptomycin and 2.5 µg/ml amphotericin B (Mediatech). The XA15A1 cells were propagated at 
33
°
C. When the cells reached 80% confluence, growth factors were omitted from the media and 
the cells were placed at 37
°
C for at least 24 hours prior to the experiment. The XA15A1 cells 
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express a temperature-sensitive mutant of the SV 40 Large T-antigen (u19tsA58) and needs to be 
incubated at 37
°
C for 24 hours to revert to a phenotype that resembles that of primary cells and 
are able to differentiate. For experiments, the cells were transfected with plasmids coding for 
SIRT1 or FOXO1 dominant negative (DN) mutants obtained through the AddGene repository 
(Herscovitch et al., 2012; J. Nakae et al., 2000; Vaziri et al., 2001). The Sirt1 DN mutation 
causes an alteration of the catalytic site and leads to a loss in deacetylation activity (Vaziri et al., 
2001). The Foxo1 DN mutant contains a deletion that truncates the transactivation domain (J. 
Nakae et al., 2000). Both the Sirt1 DN and Foxo1 DN plasmid encode for the puromycin 
resistance gene, for the selection of stably transfected cells. The two types of transfection were 
performed identically. Briefly, 5 x 10
6
 cells were transfected in a 100 μL final volume of the 
nucleofection solution V containing 1μg of plasmid DNA and the application of the T-030 
program from the Amaxa Nucleofactor 2b electroporator (Lonza Walkersville) list. For 
experiments using stably transfected cells, 10 ug/mL puromycin was added to the medium after 
24 hours to select for cells that stably integrated the Puromycin resistance gene. The cells were 
used 4 to 6 passages later.  
Preparation of Fatty Acids 
A 50 mM stock of each single fatty acid was prepared in 0.1 M NaOH. Each fatty acid 
stock was added to Dulbecco's modified Eagle's medium: F12 (DMEM:F12) containing 600 µM 
BSA, 5% calf serum, 10 mM glucose, 33 µM biotin, 17 µM D-pantothenate, containing 50 IU/ml 
penicillin, 50 µg/ml of streptomycin, and 2.5 µg/ml amphotericin B to reach a mixture consisting 
of 40% oleate, 25% palmitate, 20% linoleate, and 15% stearate. Each concentration was pre-
equilibrated for one hour with 600 µM BSA at 37
0
C. For all experiments, cells were incubated in 
600 µM BSA for at least 2 hours prior to the addition of the drugs or fatty acids (FA). To start 
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the experiment FA mixtures were added to the 600 µM BSA at a 2x concentration to equal a 
final FA concentration of 1x.  
RNA Isolation, Reverse Transcription, and Quantitative Real-Time PCR 
RNA was isolated from frozen adipose tissue samples or from cell culture samples after 
various treatments. Pieces of frozen adipose tissue of approximately 100 mg were allowed to 
unfreeze in 1 mL of RNA later ICE (Applied Biosystems, Foster City, CA). These pieces were 
homogenized and RNA isolated using the TriReagent procedure as described by the supplier 
(Sigma Aldrich). TriReagent was used, as well, for the cell culture experiments. First-strand 
cDNA was synthesized from 5 µg total RNA with the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems). Relative real-time TaqMan PCR was performed with 
primers and 6-carboxyfluorescein dye-labeled TaqMan probes (Applied Biosystems). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an endogenous control 
because it was found to be the most stable when compared to HPRT and POLII. Each reaction 
contained 5 ng cDNA from total RNA, in a total reaction volume of 10 µl. To prevent bias 
toward a specific group, the relative expression was determined by the comparative threshold 
method (Δct) using all samples as reference. 
Cell Death 
Cell death was measured by Calcein AM and Ethidium Homodimer-1 (Life 
Technologies, Grand Island, NY). Calcein AM is a live cell dye that accumulates in intact cells 
where it acquires a strong green fluorescence upon cleavage by intracellular esterases 
(Papadopoulos et al., 1994). Because intracellular esterase activity is quickly lost as cells die, 
little to no gain in fluorescence occurs in dead or dying cells. Ethidium Homodimer-1 is a dye 
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that enters the damaged plasma membrane and interacts with nucleic acids. As Ethidium 
Homodimer-1 interacts with nucleic acids the red fluorescence of the dye increases by 40 Fold, 
indicating dying or dead cells (Papadopoulos et al., 1994). At the end of the 6, 12 or 24 hour FA 
incubation periods, cells were collected and incubated for 15 minutes at room temperature in 
DPBS containing Calcein AM and Ethidium Homodimer 1 at a final concentration of 0.05 µM 
and 4 µM. To detect Calcein AM fluorescence an excitation wavelength of 488 and a 530± 30 
nm emission filter was used. Ethidium Homodimer 1 fluorescence was detected using an 
excitation wavelength of 488 and a 675 ± 25 emission filter. After subtraction of auto-
fluorescence, the live cell region was determined by examining an untreated sample and a 
sample containing only 600 µM BSA. Dead cells were determined by treating a control sample 
with 0.01% Triton-X for 15 minutes. All values for cell death represent the percent of dead cells 
found in the gated region of the cell population of interest.  
Measurement of the Ratio of Acetylated versus Total FOXO1 Proteins  
Following treatment with FA, 1.0x10
6 
cells were collected, fixed in 5% formaldehyde and 
permeabilized in 100% methanol. The non-specific binding of antibody on cells was blocked by 
incubating the cells for 60 minutes in an incubation buffer consisting of PBS containing 0.5 % 
BSA. After blocking, primary antibodies directed against total FOXO1 (sc-9808; Santa Cruz 
Biotechnology, Dallas, TX) or Ac-FOXO1 (sc-49437, Santa Cruz) were added at a 1:100 
dilution ratio in the incubation buffer. Cells were washed once and incubated with a 1:1000 
dilution of anti-goat IgG (H+L) Alexa Fluor 568 (A11057; Life technologies) and a 1:1000 
dilution of anti-rabbit IgG (H+L) Alexa Fluor 488 (4412; Cell Signaling Technology) for 30 
minutes to reveal the total and acetylated FOXO1 antibody, respectively. Alexa Fluor 488 has an 
excitation of 488 nm and an emission of 520 nm. Alexa Fluor 568 has an excitation of 568 nm 
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and an emission of 600 nm. After 30 minutes, cells were washed twice and suspended in 300 µL 
of PBS and analyzed on a flow cytometer. Auto fluorescence and nonspecific staining were 
determined by using either normal anti-rabbit IgG (Sc-2027; Santa Cruz) or normal anti-goat IgG 
(Sc-2028; Santa Cruz Biotechnology) as isotype controls, after gating on the live cell population. 
Gates were applied to each histogram that corresponded to either the 530 ±30 nm band pass filter 
or the 585 ±40 nm band pass filter. Mean fluorescence intensity (MFI) for each histogram was 
determined after gating. The ratio of Ac-Foxo MFI to Total-Foxo2 MFI was calculated and 
plotted using GraphPad Prism. 
Statistical analysis  
Statistical analysis was performed with PRISM (GraphPad Software, San Diego, CA) 
version 5.00 for Windows. Differences between ISL, ISNO, IRO and T2DM individuals were 
assessed by a one-way ANOVA, followed by Tukey’s multiple comparison tests. Differences 
between the first and last quartiles of insulin sensitivity or gene expression were assessed using a 
two-tailed unpaired Student’s T test. For in-vitro studies, differences between FA concentrations, 
600 µM BSA and/or pretreatment with MitoTempo or Ex527 were assessed by a one-way 
ANOVA with a Tukey’s multiple comparison test. All values are reported as + SD. In all cases, a 
P value of less that 0.05 was used to indicate statistical significance between conditions. 
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Results  
Subject Characteristics   
Although previous studies have treated obese individuals as a homogenous population, 
not all obese individuals respond negatively to an obesogenic environment (Klöting et al., 2010; 
Samocha-Bonet, Chisholm, Tonks, Campbell, & Greenfield, 2012). Depending on where an 
individual’s insulin sensitivity falls on the obesity continuum can dramatically influence his or 
her risk for developing metabolic and cardiovascular diseases (Klöting et al., 2010; Samocha-
Bonet et al., 2012). Since protection or adaptation to an obesogenic environment should 
determine which extreme an individual is closer to, individuals belonging to the groups of ISNO 
(insulin-sensitive non-obese), ISO, IRO and T2DM were compared (Rogers et al., 2012b). Table 
1 shows the basal characteristics of subjects following a 12-hour overnight fast. Plasma glucose 
levels were statistically increased in T2DM when compared to ISNO, ISO and IRO patients. 
Insulin levels were significantly increased in both IRO and T2DM when compared to ISNO, but 
not different between IRO and ISO individuals. Comparisons between ISNO and ISO showed no 
difference in HOMA-IR values, but there was a significant increase in the HOMA-IR value in 
both the IRO and T2DM group when compared to ISNO and ISO.  
Antioxidant enzyme gene expression in adipose tissue correlates with insulin level and insulin 
sensitivity 
Since chronic positive energy imbalance should put undue reducing pressure on the ETC 
and lead to exaggerated mitochondrial ROS production in all tissues including adipose tissue, we 
tested the hypothesis that ISO individuals maintain their adipose tissue metabolic fitness through 
higher antioxidant gene expression, while IRO individuals fail to maintain metabolic fitness due 
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to lower antioxidant gene expression. The expression level of antioxidant genes was evaluated by 
real-time PCR performed on cDNA obtained from RNA extracted from the subcutaneous 
adipose tissue of women of various ages, BMI, and insulin sensitivities. Figure 12A, C, E, G, I, 
and K shows the expression of six antioxidant genes in ISNO, ISO, IRO as well as in T2DM 
subjects. Figure 12 B, D, F, H, J, and L show the expression of these same genes in insulin-
sensitive (ISI) and insulin-resistant (IRI) individuals irrespective of their weight. The 
characteristics of the subjects, classified as being ISI or IRI using the relatively stringent first and 
last quartiles of HOMA-IR as cut-offs are described in table 2.   As show in figure 12 A and B, 
the expression of superoxide dismutase (SOD2) was lower in IRO than ISO individuals, and was 
decreased in IRI compared to ISI. Figure 12 C shows that the expression of catalase (CAT), the 
only non-mitochondrial protein of the list, was reduced in IRO and T2DM compared to ISO. 
However, no statistical difference was observed when comparing the upper and lower quartile of 
insulin sensitivity (Figure 12D). Peroxiredoxin 3 (PRDX3) expression correlated with HOMA-
IR (r=-0.37, p=0.03),insulin (r=-0.38, p=0.03) and was lower in IRI compared to ISI (Figure 
12F), (figure 12E). Thioredoxin reductase 2 (TXNRD2) expression, on the other hand, was lower 
in IRO and T2DM subjects (figure 12G) and lower in IRI compared to ISI (Figure 12H).  
Glutathione peroxidase 1 (GPX1) expression was was lower in IRI compared to ISI (figure 12J). 
Glutathione reductase (GSR) expression did not vary between any groups (Figure 12 K and L).  
SIRT1 and FOXO1 gene expression correlate to insulin sensitivity and too some extent 
antioxidant gene expression 
Although the cell, and in particular the mitochondrion, has several mechanisms that can 
buffer elevations in the level of ROS, the ability to resist repeated elevations of ROS requires an 
increase in the transcription of genes that can buffer ROS (Ikeuchi et al., 2005; Piantadosi & 
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Suliman, 2006; Sano & Fukuda, 2008). Therefore, finding the nuclear transcription factor(s) that 
regulate the transcription of antioxidant detoxification genes that correlated to insulin sensitivity 
was investigated. Although a plethora of factors have been shown to be part of the ROS hormetic 
stress response, the four genes we found in our study to be correlated with insulin sensitivity, 
SOD2, PRDX3, TXNRD2 and GPX1, are FOXO-regulated genes that contain a FOXO-binding 
element (FRE) (Biggs, Meisenhelder, Hunter, Cavenee, & Arden, 1999; Furuyama et al., 2000). 
Members of the forkhead member of the class O (FOXO) family of transcription factors have 
been shown to be recruited to the nucleus under oxidative stress conditions, and consequently 
favor the transcription of antioxidant genes after being deacetylated by the NAD+-dependent 
deacetylase sirtuins 1 (SIRT1) (Brunet et al., 2004; Kops et al., 2002; Nemoto & Finkel, 2002). 
Therefore, the prototypical stress response of SIRT1-FOXO1/3 could serve as one potential 
mechanism that links mitochondrial redox changes to transcription of antioxidant genes.   
To test this hypothesis SIRT1 or FOXO1 mRNA expression was compared between 
ISNO, ISO, IRO or T2DM individuals.  SIRT1 mRNA expression was significantly decreased in 
T2DM when compared to ISNO and IRO (Figure 13A) and was lower in IRI compared to ISI 
(Figure 13B). However, FOXO1 mRNA expression showed no significant difference between 
the ISNO, ISO, IRO and T2DM groups (Figure 13C). Nevertheless, FOXO1 mRNA expression 
was lower in IRI compared to ISI (Figure 13 D). 
To investigate whether high or low SIRT1 or FOXO1 expression correlates to antioxidant 
gene expression, samples were separated into quartiles of low (first quartile) and high (last 
quartile) of SIRT1 or FOXO1 expression. The characteristics of the subjects from the first and 
last quartile of SIRT1 expression are described in Table 3. As found in Table 3, glucose, insulin, 
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and HOMA-IR values were higher in the lower quartile of SIRT1 expression. Similarly, the 
characteristics of the subjects from the first and last quartile of FOXO1 expression are described 
in Table 4. This table shows that only the HOMA-IR values were correlated with FOXO1 
expression.  As shown in Figure 14, individuals belonging to the high SIRT1 expression quartile 
also had a high SOD2, CAT, PRDX3, TXNRD2, GPX1 and FOXO1expression (Figure 14 A, B, 
C, D, E and G) compared to individuals from the low SIRT1 quartile. However, as shown in 
Figure 14F, no statically significant difference was found in GSR expression between the low 
and high SIRT1 expression quartiles.  Like individuals from the upper quartile of SIRT1 
expression, individuals from the upper FOXO1 quartile had an increase in SOD2, PRDX3 and 
GPX1 expression (Figure 15A, C and E). No difference in expression was found between CAT, 
TXNRD2 or SIRT1 (Figure 15B, D and G) when comparing the low and high FOXO1 quartile.  
Individuals belonging to the high FOXO1 expression quartile also had a surprising decrease in 
GSR expression (Figure 15F), compared to the low FOXO1 expression quartile. 
Exposure to fatty acids in human preadipocytes cause an increase in deacetylation of FOXO1  
  After observing a positive correlation in the expression of SOD2, PRDX3 and GPX1 in 
the high expression quartile of SIRT1 and FOXO1, the ability of a mixture of fatty acids (FA) to 
stimulate the prototypical SIRT1-FOXO1 stress response in human preadipocytes was 
investigated. Preadipocytes were chosen because 1) protection of preadipocytes against lipotoxic 
insults is important in preserving adipose tissue turnover and function, 2) preadipocytes do not 
possess a high capacity to esterify FA, and therefore would be more susceptible to byproducts of 
mitochondrial FA oxidation, and 3) preadipocytes are found in locations near mature adipocytes 
leading to a constant exposure of FA (Carrière, Fernandez, Rigoulet, Pénicaud, & Casteilla, 
2003; Frayn, 2002; Tchoukalova et al., 2007).  To characterize what FA concentration may affect 
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the SIRT1-FOXO1 pathway, preadipocytes were treated with a mixture of FA in a FA to 
albumin ratio and concentration range that reflects the physiological relevant adipose tissue 
environment and evaluated for changes in the deacetylation of FOXO1 (Mittendorfer et al., 
2003; Tahiri et al., 2007).  
Preadipocytes were treated for 1, 2, 6, 12 or 24 hours with FA. Following FA treatment 
total protein level of FOXO1 (T-FOXO1) or acetylated FOXO1 (Ac-FOXO1) was measured. 
The ratio of Ac-FOXO1 to T-FOXO1 mean fluorescence intensity was shown to be significantly 
decreased at 6, 12 and 24 hours in 600 µM, 800 µM, and 1000 µM FA compared to 600 µM 
BSA indicating an increase in deacetylation was occurring (Figure 16A). To determine if the 
increase in FOXO1 deacetylation was occurring due to FA production of mitochondrial ROS, 
cells were pretreated with MitoTempo, a mitochondrial targeted superoxide and alkyl radical 
scavenger for 10 minutes followed by FA exposure. Compared to 600 µM BSA, when 
preadipocytes were pretreated with MitoTempo, no significant change in the ratio of Ac-FOXO1 
to T-FOXO1 was observed at in any of the FA concentrations, suggesting that formation of 
superoxide or alkyl radicals plays a role in triggering deacetylation of FOXO1 (Figure 16B).  In 
addition to ROS playing a role in deacetylation of FOXO1, pretreatment with the SIRT1 
inhibitor EX-527, also prevented the increase in FOXO1 deacetylation that was observed with 
1000 µM FA (Figure 16C). 
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Expression of dominant negative SIRT1 or FOXO1 further Exacerbates cell death induced by 
fatty acids 
Although FA induced an increase in deacetylation in preadipocytes at the 24 hour time 
point, the protective effect of FOXO1 deacetylation was unknown, especially since FA exposure 
caused an increase in cell death in both 800 and 1000 µM FA at 24 hours (Figure 16D). To test 
this hypothesis, a stable cell line that expressed either a dominant negative (DN) SIRT1 or 
FOXO1, was treated with FA and the percentage of dead cells was measured. Compared to 1000 
µM FA treatment in non-transfected cells, the SIRT1 DN demonstrated an almost a 2-fold 
increase in cell death when treated with 1000 µM FA (Figure 16D). The increase in cell death 
found in the SIRT1 DN was also present following 800 and 600 µM FA treatment. Interestingly, 
SIRT1 DN cells treated with 600 µM showed almost a 3-fold increase in cell death compared to 
non-transfected cells where no increase in cell death was observed (Figure 16C).  In comparison 
to SIRT1 DN, the FOXO1 DN only showed an increase in cell death above non-transfected cells 
when treated with 1000 µM FA (Figure 16C). To confirm that the exacerbation in cell death was 
due to FA entry and ROS production within the mitochondria, pretreatment of preadipocytes 
with Etomoxir, a carnitine palmitoyl transferase I (CPT-I) inhibitor, that blocks the entry of fatty 
acyl-CoA into the mitochondria or MitoTempo was used. Pretreatment with Etomoxir or 
MitoTempo followed by 1000 µM FA, diminished the increase in cell death in non-transfected, 
SIRT1 DN and FOXO1 DN cells, suggesting the FA entry into the mitochondria and subsequent 
increases in superoxide or alkyl radical formation caused the associated increase in cell death 
(Figure 16D).  
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Discussion 
  This study is the first to demonstrate that mitochondrial antioxidant gene expression is 
altered depending on insulin sensitivity across a wide range of BMI. The findings suggest that 
decreased SIRT1 activity underlies a decrease in antioxidant gene expression. This lower 
antioxidant capacity would, in turn, increase the susceptibility of adipose tissue to chronic energy 
imbalance. This sensitivity to the cytotoxic effect of excess nutrients, in particular FA, may be 
linked to the loss of insulin sensitivity. Although subjects were matched for BMI and age as 
much as possible, the influence of age, BMI or the ability of obesity to accelerate aging within 
adipose tissue may have an effect on an individual’s mitochondrial function and homeostasis.  
Although the role of FOXO1 on antioxidant gene expression was a primary focus, 
FOXO1 has also been shown to increase insulin sensitivity through transcription of insulin 
receptor substrate 1 and modulation of energy homeostasis in adipose tissue through regulation 
of adipocyte size (Armoni et al., 2006; J Nakae et al., 2008). In other non-adipose tissue, 
however, increased nuclear FOXO1 may not be beneficial. For example, in the liver, inhibition 
of FOXO1 leads to improvement in hepatic insulin action (Altomonte et al., 2003). Furthermore, 
a mouse model that mimics overexpression of deacetylated FOXO1 leads to insulin resistance 
(Banks et al., 2011). Therefore, the changes observed in FOXO1 expression should be limited to 
the context of adipose tissue and not extrapolated to other tissues.  
 Despite uncovering strong associations between SIRT1, FOXO1 and antioxidant gene 
expression, not all genes were significantly changed. For example, despite having an FRE 
sequence, no change in Catalase (CAT) expression between the different quartiles of FOXO1 
expression occurred. Furthermore, CAT and TXNRD2 were upregulated in the upper quartile 
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SIRT1 expression, but not FOXO1. Together these findings suggest that although the SIRT1-
FOXO1 axis plays an important role in regulating mitochondrial antioxidant gene expression, 
other pathways may be involved. One alternative pathway that exists that can lead to increased 
expression of CAT, is the nuclear factor erythroid 2p45-related factor 2 (NFE2L2), which 
regulates induction of not only CAT, but also SOD2, GPX1 and GSR (Surh, Kundu, & Na, 
2008). In addition to FOXO1, SIRT1 also functions to deacetylate peroxisome proliferator-
activated receptor-coactivator (PGC1a) that can increase mitochondrial biogenesis and 
antioxidant gene expression including those presented in this paper (Nemoto, Fergusson, & 
Finkel, 2005). SIRT1 can also directly interact with nuclear factor-kappa B (NFkB) to limit 
formation of pro-inflammatory cytokines such as TNFa or to decrease the transcriptional activity 
of p53 by direct interaction that could favor adipocyte death and dysfunction (Vaziri et al., 2001; 
Yeung et al., 2004). The ability of SIRT1 to deacetylate other proteins besides FOXO1 may also 
explain why the SIRT1 DN had an increase in cell death at the 600 µM FA level, while the 
FOXO1 DN did not. Although FOXO1 is the dominant isoform in adipose tissue, FOXO3, 
which can also be deacetylated by SIRT1, governs transcription of mitochondrial antioxidant 
genes such as SOD2, and subsequently this could explain why the FOXO1 DN was not as 
detrimental as the SIRT1 DN after exposure to 600 µM FA (Brunet et al., 2004; van der Horst et 
al., 2004). In summary, insulin sensitivity correlates to antioxidant enzyme expression in 
subcutaneous adipose tissue.  
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Table 1. Characteristics of the subjects from the ISNO, ISO, IRO, and T2DM groups 
(Modified from Rogers and al) 
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Table 2. Characteristics of the subjects from the ISNO, ISO, IRO, and T2DM groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
 
 
 
 
 
 
 
 
 
 
100 
 
Table 3. Characteristics of the subjects from the first and fourth quartiles of SIRT1 gene 
expression 
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Table 4. Characteristics of the subjects from the first and fourth quartiles of FOXO1 gene 
expression 
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Figure 12. Antioxidant enzyme gene expression is lower in insulin-resistant individuals 
 Individuals were classified as ISNO, ISO, IRO or T2DM and mRNA levels of SOD2, CAT, 
PRDX3, TXRND2, DPX1 and GSR were quantified through rt-pcr using GAPDH as an 
endogenous control (Figure A-L). SOD2 (A) and TXNRD2 (G) showed a decrease in expression 
between ISNO and either IRO or T2DM, while SOD2 (A), CAT (C), and TXNRD2 (G) showed 
a difference in either IRO or T2DM when compared to ISO. PRDX3 (E), GPX1 (I) and GSR (L) 
showed no difference in the level of gene expression. Separating individuals into either the first 
or the fourth quartile of insulin sensitivity, regardless of age or BMI revealed significant 
differences between SOD2 (B), PRDX3 (F), TXNRD2 (H) and GPX1 (J), but not in CAT (D) 
and GSR (L). Results are expressed as mean + SD of 10 (ISNO), 11 (ISO), 6 (IRO) and 5 
(T2DM) or 8 subjects per quartile. * P < 0.05 when compared to ISNO. + P < 0.05 when 
compared to ISO. $ P < 0.05 when compared to ISI. 
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Figure 13. SIRT1 and FOXO1 gene expression correlate with insulin sensitivity 
The mRNA expression levels of SIRT1 and FOXO1, were measured in ISNO, ISO, IRO or 
T2DM using RT-PCR. SIRT1 (A) was lower in T2DM when compared to ISNO or ISO 
individuals. No difference in the mRNA level of FOXO1(C) was observed between ISNO, ISO, 
IRO or T2DM individuals. After separating individuals into the first and fourth quartile of insulin 
sensitivity, the expression of SIRT1 (B) and FOXO1 (D) was significantly higher in the insulin-
sensitive quartile. Results are expressed as mean + SD of 10 (ISNO), 11 (ISO), 6 (IRO) and 5 
(T2DM) or 8 subjects per quartile. * P < 0.05 when compared to ISNO. + P < 0.05 when 
compared to ISO. $ P < 0.05 when compared to ISI. 
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Figure 14.  Individuals with high SIRT1 expression have an increase in antioxidant enzyme 
gene expression 
SOD2 (A), CAT (B), PRDX3 (C), TXNRD2 (D), GPX1 (E) and FOXO1 (I) gene expression was 
higher in individuals who had increased SIRT1 expression. There was no difference in GSR (F) 
expression between the groups.  Results are expressed as mean + SD of 8 subjects per quartile. # 
P < 0.05 when compared to individuals belonging to the low SIRT1 expression quartile.  
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Figure 15.  Individuals with high FOXO1 expression are associated with an increase in 
antioxidant enzyme gene expression 
SOD2 (A), PRDX3 (C), GPX1 (E) and GSR (F) gene expression was higher in individuals who 
had increased FOXO1 expression. There was no difference in CAT (B), TXNRD2 (D) or SIRT1 
(G) expression between the groups.  # P < 0.05 when compared to individuals belonging to the 
low FOXO1 expression quartile.  
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Figure 16. FOXO1 and SIRT1 play a role in protecting human preadipocytes from cell 
death induced by fatty acids 
 (A) Preadipocytes were exposed to fatty acid for 1, 3, 6, 12 or 24 hours. After each time point 
cells were fixed and either total FOXO1 (Alexa Fluor 568) or acetylated FOXO1 (Alexa Fluor 
488) protein levels were determined by flow cytometry. Analysis of the ratio of Ac-FOXO1 
mean fluorescence intensity (MFI) to total-FOXO1 MFI revealed that fatty acid caused a 
decrease in acetylation as soon as 6 hours after treatment. Pretreatment with MitoTempo (B), a 
mitochondrial superoxide and alkyl radical scavenger, or EX-527 (C) a SIRT1 inhibitor, 
prevented the observed deacetylation of FOXO1. (D) Cells were stained with Calcein AM to 
detect live cells and Ethidium Homodimer 1 to detect dead cells. The percentage of dead cells 
was significantly increased in SIRT1 DN and FOXO1 DN following 1000 µM FA exposure 
when compared to 1000 µM FA exposure in non-transfected cells. Pretreatment with Etomoxir or 
MitoTempo prevented the increases in cell death that followed 1000 µM FA exposure. * P < 0.05 
when compared to 600 µM BSA. + P < 0.05 when compared to 1000 µM FA.  
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CHAPTER 6: INTEGRATED SUMMARY AND FUTURE DIRECTIONS 
Major Findings 
 The aims of this study were to determine the impact of fatty acids (FA) on preadipocyte 
function with specific emphasis placed on how mitochondria integrate and adapt to 
concentrations of FA within the limits of daily FA exposure.   Toward these objectives, the 
findings presented here are important for a number of reasons. First, this study shows that 
preadipocytes, despite belonging to the adipocyte lineage are susceptible to a physiologically 
relevant mixture of FA. Second, FA induce a transient increase in mitochondrial, but not 
cytosolic superoxide, H2O2 and lipid peroxidation within the first 2 hours of FA exposure that 
manifests into a loss of mitochondrial fitness over the course of 24 hours.  Third, despite one-
third of cells undergoing cell death, the majority of cells were able to survive the upper limit of 
FA exposure through a protective response initiated by a SIRT1-FOXO1 mediated increase in 
mitochondrial gene expression. Finally, global expression of SIRT1, FOXO1 and mitochondrial 
antioxidant genes is increased in adipose tissue of insulin sensitive individuals. Altogether these 
studies demonstrate for the first time how human preadipocytes are able to function during 
constant FA exposure and how preadipocyte mitochondrion susceptibility to FA can lead to the 
preadipocytes demise. 
Future Directions 
The studies presented within this dissertation describe the mechanisms that underlie 
preadipocyte susceptibility and survivability to FA. Of the numerous effects of FA exposure that 
were observed, a transient increase in superoxide and H2O2 was shown to be the initial step in 
priming preadipocytes for a loss in mitochondrial fitness through NAD+ depletion. However, 
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several questions of how FA influence preadipocytes are still unknown and call for future 
investigation.  
First, in addition to Etomoxir and MitoTempo pretreatment, Nicotinamide 
supplementation also prevented the increase in preadipocyte cell death.  However, like Etomoxir 
and MitoTempo, 2 hour post treatment with Nicotinamide failed to prevent FA induced cell 
death. Furthermore, the depletion of NAD
+
 + NADH occurs 6-8 hours following FA exposure, 
suggesting that metabolism of nicotinamide to NAD+ may be affected.  For nicotinamide to 
increase mitochondrial NAD+ pools, it first must be converted into nicotinamide mononucleotide 
(NMN) (Revollo et al., 2007; Rongvaux et al., 2003). Once NMN is formed it can freely enter 
mitochondria and be converted into NAD
+
 by Nicotinamide mononucleotide adenylyl transferase 
(NMNAT3) (Nikiforov, Dölle, Niere, & Ziegler, 2011). If mitochondrial lipid peroxidation can 
occur within the first 2 hours of FA exposure, mitochondrial protein oxidation and loss of protein 
function could also occur (Davies, Fu, Wang, & Dean, 1999). If NMNAT3, is damaged by 
excessive ROS and is unable to convert NMN from nicotinamide to NAD+, no increase in 
mitochondrial NAD+ levels would occur (Nikiforov et al., 2011). Investigation into the function 
of NMNAT3 in the presence of FA would help to reveal if this is why nicotinamide is efficient at 
saving preadipocytes from cell death after 2 hours of FA exposure. 
Second, how FA exposure signals from the mitochondria to the nucleus to increase 
antioxidant gene expression is still unclear. One potential pathway that could trigger increases in 
antioxidant genes is through JNK, as JNK inhibitor SP600125 prevented deacetylation of 
FOXO1. As H2O2 levels increase, antioxidant enzymes such as PRDX3 will interact with H2O2, 
leading to the formation of H2O (Cox et al., 2009). Once PRDX3 becomes oxidized, TRX2 can 
reduce the oxidized cysteine groups of PRDX3 (Chae, Chung, et al., 1994; Chae, Uhm, et al., 
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1994). However, for TRX2 to regenerate PRDX3, it first must dissociate from its complex with 
apoptosis signal-regulating kinase (ASK1) (Gotoh & Cooper, 1998; Hsieh & Papaconstantinou, 
2006; Saitoh et al., 1998). Once TRX2 dissociates ASK1, ASK1 can then activate JNK (Nadeau, 
Charette, & Landry, 2009). Once activated, JNK can then interact with SIRT1 (Nasrin et al., 
2009), which in turn deacetylates FOXO1. Furthermore, although this dissertation focused on the 
FOXO1 transcription, several other transcription factors that could influence antioxidant 
expression exist. Three additional transcription factors that may be involved in protection against 
FA exposure are nuclear factor E2-related factor 2 (NRF2), peroxisome proliferator-activated 
receptor-coactivator (PGC1 α), and peroxisome proliferator-activated receptor gamma (PPAR 
α). All three enzymes once activated can lead to an increase in genes involved in oxidant 
detoxification, FA oxidation and mitochondrial biogenesis(Lee, Calkins, Chan, Kan, & Johnson, 
2003; H. Liang & Ward, 2006; T. Nguyen, Yang, & Pickett, 2004; Tyagi, Gupta, Saini, Kaushal, 
& Sharma, 2011) . Exploring the role of these transcription factors as well as the signals that are 
amplified in the mitochondria and released into the cytosol upon FA exposure, would help to 
reveal if a central node in the pathway exists that can be used to up regulate and defend against 
FA induced ROS. 
Finally, this dissertation showed that pretreatment with the antioxidant Mito-Tempo or 
the NAD+ precursor Nicotinamide, prevented the increase in cell death that was associated with 
1000 µM FA. Interestingly, variations of these compounds, CoEnzyme Q10 as an antioxidant 
(Ernster & Dallner, 1995; Potgieter, Pretorius, & Pepper, 2013) and Niacin for a precursor to 
NAD+ (Bogan & Brenner, 2008; Sauve, 2008), can be found in the vitamin section of the 
majority of health stores. Therefore, an individual who is at risk for the development of adipose 
tissue dysfunction could take a nutraceutical approach to decrease their risk. Future studies in an 
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animal model examining if pretreatment or post treatment with these compounds could prevent 
the associated increases in adipose tissue dysfunction associated with a high fat diet would add 
support to this hypothesis. 
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East Carolina University 
 
 
 
Consent to Participate in Research that is 
Greater than Minimal Risk 
Information to Consider Before Taking Part in This Research 
Title of Research Study: Fatty acids and redox homeostasis in adipocytes 
 
Principal Investigator: Jacques Robidoux, PhD. 
Department of Pharmacology and Toxicology, East Carolina Diabetes and Obesity Institute, 
Brody School of Medicine 
Address: 6S10 Brody School of Medicine, Greenville, NC 27834 
Telephone #: 252-744-2741 (Lab), 252-744-5909 (Office) 
 
Research performed at the East Carolina Diabetes and Obesity Institute (ECDOI) aims to provide 
understanding, to prevent or to treat metabolic disorders with an emphasis on diabetes and 
obesity. Our goal is to try to find ways to improve the quality of life. To accomplish this, we 
need the help of people who are willing to take part in this research. 
 
The person who is in charge of this research project is called the Principal Investigator. Dr. 
Jacques Robidoux is the Principal Investigator of this project. Dr. Robert Hickner and Dr. Darrell 
Neufer are his collaborators. Artie Carlyle Rogers is a graduate student. Angela Clark is a 
registered nurse. Barbara Davis is the study coordinator. They will perform some of the 
procedures. Dr. Robert J. Tanenberg is overseeing the medical issues associated with the project.   
 
The person explaining the research to you may be someone other than Jacques Robidoux, PhD. 
Artie Carlyle Rogers or Barbara Davis may be explaining the research to you as well as asking 
you to take part in this study. 
 
You may have questions that this form does not answer. If you do have questions, feel free to ask 
the person explaining the study to you. You may have questions later and you should ask those 
questions, as you think of them. There is no time limit for asking about this research. 
 
You do not have to take part in this research. Take your time and think about the information that 
is provided. If you want, have a friend or family member go over this form with you before you 
decide whether or not to participate. It is up to you. If you choose to be in the study, then you 
should sign the form when you feel comfortable that you understand the information provided 
below. If you do not want to take part in the study, you should not sign this form. That decision 
is yours and it is okay to decide not to volunteer. 
 
This form explains why this research is being done, what will happen during the research, and 
what you will need to do if you decide to participate in this research.   
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Why is this research being done? 
 
The purpose of this research study is to understand the reasons why some overweight/obese 
individuals develop insulin resistance and type 2 diabetes. Insulin resistance is a state in which 
you need more insulin (a hormone released by your pancreas) to keep your blood glucose (sugar) 
in the normal range. Type 2 diabetes develops when your body does not produce enough insulin 
to overcome insulin resistance. We are especially interested in trying to understand why some 
overweight or obese individuals do not develop these metabolic disorders. We are asking you to 
take part in this research. However, the decision is yours to make. By doing this research, we 
hope to learn new ways to prevent insulin resistance and ultimately type 2 diabetes. 
 
 
Why am I being invited to take part in this research? 
 
You are being invited to take part in this research because you are a man or a premenopausal 
woman, 18-45 years old and overweight or obese. If you volunteer to take part in this study, you 
will be one of about 60 people to do so.  
  
 
Are there reasons I should not take part in this research?  
 
I understand I should not volunteer for this study if I am diabetic, a smoker, under 18 or over 45 
years of age, take part in regular physical activity (greater than 45 minutes per day, more than 2 
days per week), I am pregnant, lactating or trying to get pregnant, taking any hormone therapy 
(including hormonal birth control), taking drugs to control my blood glucose, lipids, or blood 
pressure, or if I am actively trying to lose weight.   
 
 
Where is the research going to take place and how long will it last? 
 
The research procedures will be conducted at the East Carolina Heart Institute (ECHI).  You will 
need to come to the ECHI rooms 2377/2379 up to three times. The initial screening visit takes 
about 40 minutes. The second screening visit takes slightly more than 2 hours. The third visit 
takes about 2 hours. The total amount of time you will be asked to volunteer for this study could 
be up to 5-6 hours over a period of 2-3 months. 
 
What will I be asked to do? 
 
Initial Screening visit (about 40 minutes) 
 
FOR THIS VISIT AND ALL OTHER VISITS YOU WILL BE FASTING 
(no food or drink other than water after 10pm the night before). 
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If you consume anything, please call us. We will have to reschedule the screening procedure 
at the next available date. If you eat, the data collected will not be valid! 
 
Medical and Family History Questionnaire: Before beginning the study, you will complete a 
medical and family history questionnaire to provide information on your ancestry, medical 
history of your blood related family, and your health and medical status. Completion of the 
questionnaire will take approximately 20 minutes. 
 
We will ask that you do not change your activity level, dietary habits or any medication you 
are taking during the time you are taking part in this study.  If this becomes a concern 
during your participation we ask you to contact us and let us know as soon as possible.   
 
  Determination of fasting and glucose and insulin levels. Because we want to understand the 
difference between insulin-sensitive and insulin-resistant individual we will draw blood from 
you to measure your plasma glucose (sugar), nonesterified fatty acids (lipids) and insulin 
(hormone) levels. Blood samples will be drawn from an intravenous (IV) catheter placed in a 
vein in your arm by, or under the supervision of, Angela Clark RN, a registered nurse. This 
procedure will take less than 5 minutes and the blood sample will amount to about half of a 
teaspoon (2.7 mL).     
 
Height and weight measurements. Height and weight will be taken by having you stand on a 
medical scale with a height rod. This test will last less than 5 minutes. 
 
Waist to Hip ratio. Waist and hip circumferences will be taken with a tape measure against the 
skin around the waist and hip regions. This test will last less than 5 minutes. 
 
Second Screening visit (about 2 ½ hours) 
 
Only if the first screening visit suggests that you are very insulin-sensitive or 
very insulin-resistant will you be invited to participate in the second 
procedure.   
 
FOR THIS VISIT YOU WILL BE FASTING 
(no food or drink other than water after 10pm the night before). 
 
If you consume anything, please call us. We will have to reschedule the screening procedure 
at the next available date. If you eat, the data collected will not be valid! 
 
Two hour, five-sample oral glucose tolerance test (OGTT). Blood samples will be drawn from an 
intravenous (IV) catheter placed in a vein in your arm by, or under the supervision of, Angela 
Clark RN, a registered nurse. These blood samples will be taken just before and 30, 60, 90, 120 
minutes after ingestion of 75g glucose. These samples will be used to determine blood 
concentration of glucose, nonesterified fatty acids, and insulin. The total amount of blood drawn 
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as part of this study will be approximately 2.5 teaspoons (5 X 2.7 mL). This amount is very small 
compared to the total amount (about a gallon) of blood that you have.  
 
 
Third visit: Fat biopsies (about 2 hours) 
 
FOR THIS VISIT YOU WILL BE FASTING 
(no food or drink other than water after 10pm the night before). 
 
If you consume anything, please call us. We will have to reschedule the screening procedure 
at the next available date. If you eat, the data collected will not be valid! 
 
 
Adipose tissue (fat) biopsies.   You will undergo two biopsies: 1) to determine the level of 
oxidized proteins (which may be a cause of insulin resistance) and the expression of genes that 
could protect or lead to insulin resistance; 2) to isolate fat cell precursors (cells that can develop 
into fat cells) that will be grown in the laboratory. These cells will be exposed to lipids and we 
will measure the cell’s response to lipids. For this procedure, a small amount of anesthesia (less 
than 1 teaspoon of 1% Lidocaine) will be injected in a ½ inch area under the skin of your 
abdomen a few inches to the left side of your belly button.   About 1 teaspoon of saline (salt 
water) will also be injected under the skin. Adipose tissue (fat) will be aspirated (sucked out) 
using a needle with suction provided by a large syringe. Less than a gram (one fifth of a 
teaspoon) of subcutaneous adipose tissue will be collected this way. This procedure will, if you 
still consent, be repeated on the right side of your belly button. Because there is an extremely 
remote risk of allergic reaction to the Lidocaine anesthesia, risk will be minimized by using 
subjects who have had prior exposure to Lidocaine or Novocaine anesthesia or by having a 
physician available during the biopsy procedure for those subjects who have not had previous 
exposure to “caine-type” anesthetics.  You should tell us now if you are allergic to “caine-type” 
anesthetics. For example, if you have had an allergic reaction to an injection at the dentist’s 
office. You should also tell us now whether or not you have been exposed to a caine-type 
anesthetic (for example at the dentist office or during a prior biopsy). Robert Hickner, Ph.D, will 
perform the biopsies under the medical coverage of Dr. Robert Tanenberg, MD 
 
What possible risks or discomforts might I experience if I take part in the 
research? 
 
There are always risks (the chance of harm) when taking part in research.  We know about the 
following risks or discomforts you may experience if you choose to volunteer for this study.  
These are called side effects.  The following side effects are known to occur in some people: 
 
  Medical history: Risk of feeling embarrassed or a loss of privacy. To minimize these risks, you 
will fill out the forms in a private area. All information collected will not be associated with your 
name, will be kept confidential, and your name will not appear on any forms containing any data 
obtained from you. You will be given an identification number which will be your only identifier 
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throughout the study including the archiving of your samples and the analysis of the data 
obtained from these samples. 
 
Weight and circumference measurement. Risk of feeling embarrassed or a loss of privacy. To 
minimize these risks, these measurements will be performed in a private area. All information 
collected will not be associated with your name, will be kept confidential, and your name will 
not appear on any forms containing any data from you. You will be given an identification 
number which will be your only identifier throughout the study including the archiving of your 
samples and the analysis of the data obtained from these samples.  
 
Overnight fasting may cause hunger and possibly dizziness. By scheduling the research 
procedures from 8 -10 AM this discomfort will be minimal and will be relieved within minutes 
after the procedures when you will be allowed to drink and eat.  
 
Risks associated with an IV catheter and blood draw are small and can include hematoma (minor 
swelling and bruising) and infection.  The insertion of the IV catheter will be performed by 
qualified personnel to reduce these risks. 
 
Fat Biopsies - Robert Hickner, Ph.D, will perform the fat biopsies with Dr. Robert J. Tanenberg, 
MD providing medical coverage.  There is a small risk of hematoma or infection around the 
biopsy site, as well as mild tenderness and bruising.  The risk will be minimized by using sterile 
procedures and applying pressure to the biopsy site until the minor bleeding has stopped.  You 
will feel mild pain, similar to the pain you feel when receiving a shot in the arm, during the 
injection of numbing medication (Lidocaine) under the skin over your abdominal adipose tissue 
before the adipose tissue biopsy.  Because there is an extremely remote risk of allergic reaction 
to the Lidocaine anesthesia, risk will be minimized by using subjects who have had prior 
exposure to Lidocaine or Novocaine anesthesia or by having a physician available during the 
biopsy procedure for those subjects who have not had previous exposure to “caine-type” 
anesthetics. You cannot participate in this research if you knowingly have heart disease or any 
condition that could result in excessive bleeding.   
 
There is also the risk of potential embarrassment during the collection of adipose tissue biopsies.  
This risk will be minimized by the involvement of minimal staff associated with the procedure 
and conducting the procedure in a private room or behind a privacy curtain. 
  
There is always a chance that any medical intervention may cause you some discomfort or harm 
and the procedures in this study are no different.  We will do everything possible to keep you 
from being harmed.  There may be other risks or side effects that occur which we do not know 
about at this time. 
 
It is important for you to tell us as quickly as possible if you experience a side effect. 
 
 
Are there any reasons you might take me out of the research?   
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There may be reasons we will need to take you out of the study, even if you want to stay in. We 
may find out that it is not safe for you to stay in the study. It may be that the side effects are so 
severe that we need to stop the study or take you out of the study to reduce your risk of harm.  If 
we find that the research might harm you or that it is not providing enough of a benefit to justify 
the risks you are taking, we will contact you immediately with an explanation of why you can no 
longer participate and give you copies of results from any screening or research tests that would 
be of interest to you or your primary care physician. We may also find that you cannot come for 
your study visits as scheduled.  If that is found to be true, we will need to take you out of the 
study. Finally there are scientific reasons. The principal reasons are that you are not clearly 
insulin-sensitive or sensitive-resistant. Because we want to understand the difference between 
these two groups we will have to stop your participation in the study if you do not clearly fall 
into these two groups.   
 
 
What are the possible benefits I may experience from taking part in this 
research? 
 
There may be no personal benefit from your participation but the information gained by doing 
this research may help others in the future. 
 
 
Will I be paid for taking part in this research? 
 
We will pay you for the time you volunteer while being in this study.  Compensation will be 
provided according to the visits you complete as part of the study.  $25 will be provided for the 
consent visit, $50 for the second (first screening visit), $75 for the third (second screening visit), 
$75 for the fourth (fat biopsy visit); for a possible total of $225. Appropriate compensation will 
be provided after completion of the study or after your participation in the study has stopped for 
any reason.  
 
 
What will it cost me to take part in this research?  
 
It will not cost you any money to be part of the research; it will only cost your personal time.  
You will be responsible for providing your own transportation to and from the ECHI for each 
study related visit. There is no service provided that requires a cost on your or on our part. The 
cost of this research is assumed by the researcher’s funding. 
 
 
Who will know that I took part in this research and learn personal 
information about me? 
 
To do this research, you may meet with the study coordinator, research nurses, and study staff 
including Dr. Hickner who will perform the biopsies and Dr. Robert J. Tanenberg, who oversees 
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the medical aspects of the research.  All other individuals that do not have  physical contact with 
you, which include these same individuals and others when processing the samples, the data 
from the samples, or the data from the questionnaires you filed, will only know you by your 
identification number.  These people are ECU staff and the people and organizations listed 
below.  
 
The research team, including the Principal Investigator, study coordinator, research nurses, and 
all other research staff or students involved in conducting the study.   
All of the research sites’ staff.  These are the research and medical staff at the ECHI 
Any agency of the federal, state, or local government that regulates this research. This includes 
the Department of Health and Human Services (DHHS), the North Carolina Department of 
Health, and the Office for Human Research Protections  
The ECU University & Medical Center Institutional Review Board (UMCIRB) and the staff who 
have responsibility for overseeing your welfare during this research, and other ECU office staff 
who oversee this research. 
 
 
How will you keep the information you collect about me secure and how long 
will you keep it? 
 
The confidentiality of information collected from volunteers of this study will be ensured by 
numeric coding of all data. Data will be secured on password encrypted computers, in the office 
of Dr. Robidoux and in a secondary backup file contained in a locked filing cabinet also in Dr 
Robidoux’s office. The data will be kept for at least 10 years. Samples will be stored in freezers 
for at least 10 years.  It is possible that the information collected in this study will be used in 
professional publications, conference presentations or for future research projects, but all data 
will be stripped of any personal identifiers so no one will associate you with the research project. 
 
 
What if I decide I do not want to continue in this research? 
 
Participating in this study is voluntary. If you decide not to participate in this research after it has 
already started, you may stop at any time. You will not be penalized or criticized for stopping.  
 
 
What if I get sick or hurt while I am in this research? 
 
 
If you are harmed while taking part in this study: 
 
If you believe you have been hurt or if you get sick because of something that is done during the 
study, you should call and tell us immediately. There are procedures in place to help attend to 
your injuries or provide care for you. Costs associated with this care will be billed in the ordinary 
manner, to you or your insurance company. However, some insurance companies will not pay 
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bills that are related to research costs. You should check with your insurance company about 
this. Medical costs that result from research-related harm may also not qualify for payments 
through Medicare, or Medicaid. You should talk to the study coordinator, the principal 
investigator or Dr. Robidoux about this, if you have concerns. 
 
If you need emergency care:   
 
Call 911 for help.  It is important that you tell the doctors, the hospital or emergency room staff 
that you are taking part in a research study and the name of the Principal Investigator.  If 
possible, take a copy of this consent form with you when you go.   
 
Call Barbara Davis at (252) 341-9475 days or nights and weekends, Artie Carlyle Rogers at 
(252) 802-2123 days or nights and weekends or Dr. Jacques Robidoux at (252) 702-9004 days or 
nights and weekends. We need to know if you are hurt or ill.   
 
If you do NOT need emergency care, but have been hurt or get sick: 
 
Call Barbara Davis at (252) 341-9475 days or nights and weekends, Artie Carlyle Rogers at 
(252) 802-2123 days or nights and weekends or Dr. Jacques Robidoux at (252) 702-9004 days or 
nights and weekends. We need to know that you are hurt or ill. As necessary, go to your regular 
doctor. It is important that you tell your regular doctor that you are participating in a research 
study.  
 
 
Who should I contact if I have questions? 
 
The people conducting this study will be available to answer any questions concerning this 
research, now or in the future.  You may call Barbara Davis at (252) 341-9475 days or nights and 
weekends, Artie Carlyle Rogers at (252) 802-2123 days or nights and weekends or Dr. Jacques 
Robidoux at (252) 702-9004 days or nights and weekends. 
 
If you have questions about your rights as someone taking part in research, you may call the 
ECU Institutional Review Board Office at phone number 252-744-2914 (days).  If you would 
like to report a complaint or concern about this research study, you may call the Director of 
UMCIRB Office, at 252-744-1971 (days). 
 
 
Is there anything else I should know? 
 
You can limit the amount and type of information that is shared and you must make this request 
in writing. We will make sure that no information is linked to your name except for the files 
containing your name and your identification number. These files (the original and the backup 
file) will not be shared and will be locked in Dr. Robidoux’s office. The identification number 
associated data will be accessed and used by the research staff and may be shared with other 
ECU researchers and other organizations as is deemed necessary. Research information 
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continues to be reviewed long after study completion, so it is difficult to say when the use of 
your information will stop. There is not an expiration date for the use of your information for this 
study. 
 
 
I have decided I want to take part in this research.  What should I do now? 
 
The person obtaining informed consent will ask you to read the following and if you agree, you 
should sign this form:   
 
I have read (or had read to me) all of the above information.   
I have had an opportunity to ask questions about things in this research I did not understand and 
have received satisfactory answers.   
I understand that I can stop taking part in this study at any time.   
By signing this informed consent form, I am not giving up any of my rights.   
I have been given a copy of this consent document, and it is mine to keep.  
 
 
          _____________ 
Participant's Name  (PRINT)                                 Signature                            Date   
 
Person Obtaining Informed Consent:  I have conducted the initial informed consent process.  I 
have orally reviewed the contents of the consent document with the person who has signed 
above, and answered all of the person’s questions about the research. 
 
 
             
Person Obtaining Consent  (PRINT)                      Signature                                    Date   
 
 
 
Jacques Robidoux           
Principal Investigator   (PRINT)                           Signature                                    Date   
 
(If other than person obtaining informed consent) 
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APPENDIX C: FLOW CYTOMETRY DOTPLOT SHOWS NO CHANGE IN FSC OR 
SSC 
Figure 17. (A) Analysis of 600 μM BSA and 100 µM H2O2 showed no shift in the forward or 
side scatter at 5, 15, and 30 minutes. (B) Flow cytometry gates were applied between 600 μM 
BSA and 100 μM H2O2 were kept constant during the course of the experiment. (C) The density 
plot of CM-H2DCFDA fluorescence vs. time of 100 μM H2O2 was sectioned into different (D) 
quadrants. Each quadrant was (E) pseudo-colored and plotted on the (F) forward scatter vs. side 
scatter dot plot to determine if the change in fluorescence associated with 100 μM H2O2 
occurred in a single cell homogenous fashion. (G) Overlay of the gated region with the pseudo-
colored dot plot revealed that the selected population exhibited a homogenous response to H2O2.  
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APPENDIX D: ISOTYPE STAINING OF TOTAL AND AC-FOXO1 ANTIBODIES IN 
PREADIPOCYTES 
 
Figure 18. To ensure the fluorescence we observed was not due to background, we incubated 
cells in antibodies targeting total Foxo1, Ac-Foxo1, non-specific IgG rabbit and IgG goat 
antibodies. Data indicate that the fluorescent signal obtained is not due to non-specific staining. 
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